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Abstract 
Pathogenic Mycobacteria persist in an early endosome-like compartment by interfering with 
late endosomal fusion mediating factors. Studies have unraveled some of the mechanisms 
employed by mycobacteria to create a niche for themselves in macrophages, but it is widely 
accepted that they possess an arsenal of weapons to impede phagosome genesis. 
M. marinum has gained importance in recent years, as a model organism to study 
mycobacterial pathogenesis due to its phylogenetic closeness to M. tuberculosis. The 
infection it causes in its natural hosts display characteristic features of tuberculosis, exhibiting 
blocking of phagosome maturation and granuloma formation.  
To gain insight into the genes required for the inhibition of phagosome maturation, M. 
marinum transposon mutant library representing knock outs covering the entire genome was 
sifted for mutants defective in inhibiting phagosome maturation by designing an elegant 
screen, which employs magnetic separation. In this process we identified a number of mutants 
unable to inhibit phagosome maturation and characterised in detail one of these mutants 
(mutant P1). The colony morphology and sequence analysis revealed that the interrupted gene 
of mutant P1 (pmiA) is likely to be involved in lipid metabolism. The mutant also had a 
reduced intracellular survival as inferred from the in vitro bacterial survival experiments in 
HMDM and using mice as an in vivo model. The mutant completely reverted to its wild-type 
phenotype when complemented with the respective gene from wild-type M. marinum. Thin 
layer chromatography on the lipids isolated from the mutant showed that the disruption of the 
gene pmiA in mutant P1 leads to the loss of a glycolipid of the outer envelope of M. marinum 
(Robinson N et al., Infect Immun. 2007 Feb;75(2):581-91). 
The missing glycolipid was further characterised to be a phenolic glycolicpid (PGL) using 
mass spectrometry and nuclear magnetic resonance spectroscopy. In order to prove that the 
lipid is capable of inhibiting phagosome maturation, it was extracted from wild-type M. 
marinum, coated on to hydrophobic beads and chased into human monocyte derived 
macrophages (HMDM). Characterising the phagosomes containing the beads by western blot 
analysis and immunofluorescence microscopy proved the lipid to be a key molecule employed 
by virulent mycobacteria to inhibit phagosome maturation.  
Phagosomes were characterised employing an efficient adenoviral transfection system 
harbouring Rab-GFP fusion proteins to transfect primary phagocytes. This transfection 
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system enables phagosome maturation to be studied efficiently by fluorescence microscopy in 
live cells, in contrast to immunostaining which can be performed only on fixed cells.  
The gene pmiA involved in the biosynthesis of the phenolic glycolipid shows little homology 
with the gene sequences available through genome databases. It also does not display any 
signature sequences of proteins with known functions. Therefore, an attempt was made to 
study its interacting proteins by using Histidine-tag pull down assay. Proteins interacting with 
pmiA were analyzed by mass spectrometry. A methyl transferase and an isocitrate lyase, both 
enzymes critically involved in lipid biosynthesis were found to interact with pmiA. Our 
results prove that genes involved in the synthesis of this phenolic glycolipid are ideal 
pharmacological targets to design drug interventions against tuberculosis. 
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 1  Introduction 
1.1 Tuberculosis 
Tuberculosis (TB) is a chronic infectious disease which has afflicted humanity for over 
35,000 years. Its etiological agent Mycobacterium tuberculosis (Mtb) has accounted for 
more human deaths than any other pathogen to date. TB is also an old disease in terms 
of its documentation. Descriptions of the pulmonary lesions in patients who had died of 
consumption were clearly documented by the French physician Rene Theophile 
Hyacinthe Laennec in his landmark work “A treatise on disease of the chest” in 1821. 
Another French physician Jean-Antoine Villemin published in 1868 “Etudes sur la 
Tuberculosis” (studies on tuberculosis) identifying the infectious nature of tuberculosis. 
Villemin had also provided proof of transmissibility of the disease. The job of 
identifying the causative agent of TB was left to Robert Koch, who announced his 
discovery at a meeting of the Physiological Society of Berlin on 24 March 1882. Koch’s 
contributions to the study of TB were enormous. The staining technique developed by 
Koch still remains an important tool in diagnosing TB. These documentations prove the 
antiquity of the TB (Daniel, 2006). TB continues to have a devastating impact globally, 
claiming the lives of approximately 2 million people yearly worldwide. Every year 8 
million people become newly infected with the Mtb and has been noted that a person 
becomes infected with the bacilli every second (WHO, 2006). These staggering 
statistics remain true despite the fact that TB is one of the first infectious diseases for 
which a vaccine and drugs became available. 
1.1.1 TB Pathogenesis 
TB predominantly develops in the lung. Mtb is transmitted by the expulsion of nasal 
droplets from an infected individual to an uninfected one. These droplets containing the 
bacilli are able to reach the alveoli of the respiratory tract. Alveolar macrophages and 
probably dendritic cells (DC), which screen the mucosa for foreign organisms, ingest 
the tubercle bacilli. The alveolar macrophages are usually equipped to destroy any 
invading pathogen. Virulent mycobacteria have devised mechanisms to survive in the 
hostile environment of these macrophages. Therefore, these alveolar macrophages serve 
as mobile habitat. It is widely postulated that alveolar macrophages in the airways, are 
stimulated to invade the lung epithelium following internalization of inhaled bacteria. 
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The invading macrophages loaded with the bacilli produce tumour necrosis factor alpha 
(TNF-α) and other inflammatory chemokines, resulting in the recruitment of successive 
waves of neutrophils, natural killer (NK) T-cells, CD4+ T-cells and CD8+ T-cells. Each 
of these cells produces their own complement of cytokines and chemokines that amplify 
cellular recruitment, resulting in the remodelling of the infection site. This 
inflammatory cascade is regulated and superseded by a specific cellular immune 
response that is linked to the production of interferon gamma (IFN-γ). At this stage the 
bacteria multiply inside the macrophages, leading to the recruitment of more and more 
macrophages and inflammatory cells. This marks the formation of stable granuloma. 
More mature phase granulomas show marked neo-vascularization and develop an 
extensive fibrotic capsule that delineates the margin between the macrophages, 
granulocytes, foamy macrophages and giant cells. The granulomas thus formed can be 
either progressive or non-progressive. Progressive granulomas in the later stages lose 
their vascular appearance and become necrotic leading to the development of caseous 
necrosis. Caseous necrosis starts in the centre of the granuloma, as a result of killing of 
macrophages in which the bacilli multiply. The size of the caseous lesion is proportional 
to the bacillary load. One of the most intriguing observations is the relative distribution 
of bacteria and bacterial products. Several studies noted that although bacteria were 
found in the central necrotic region of the lesion, a significant proportion of bacteria 
were associated with macrophages in the peripheral leukocytic infiltrate. These 
macrophages have been found bordering the necrotic region and outside the fibrotic 
capsule. One possible explanation could be that the macrophages walling the caseous 
center ingest the bacteria escaping from the edge of the caseum.  
The human tuberculosis granuloma is the product of a cellular immune response to 
various mycobacterial components. In AIDS patients diminished capacity to mount a 
CD4+ dependent T-cell response correlates with reduced granuloma forming capacity 
and consequently a reduced ability to prevent metastasis of infection. Although studies 
indicate that granuloma structures deal with the containment of infection and 
transmission as a breakdown of immunoregulation, mycobacteria have a vested interest 
in driving transmission (Russell, 2007). How does Mtb influence this process to 
maximize its survival and subsequent transmission under strong immune pressure? The 
propensity of virulent mycobacteria to invade host macrophages by inhibiting 
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phagosome maturation (PM) is considered central for the pathogen’s effective 
pathogenicity, latency and transmission. 
1.2 Virulent Mycobacteria Inhibit Phagosome Maturation  
Mtb and other virulent mycobacteria lik Mycobacterium bovis, Mycobacterium avium 
and Mycobacterium marinum dwell in macrophages by modifying the phagosome 
according to their requirements and thus preventing PM. This is a signature mechanism 
of virulent mycobacteria. A deeper understanding of the different signalling events 
involved in PM is necessary for the evaluation of mycobacterial principles that 
participate in the inhibition of PM. 
1.2.1 Phagosome Maturation 
The process by which cells internalize large foreign particulate matter is termed 
phagocytosis, which was first popularized by Ilya Metchnikoff by the end of the 19th 
century. Immunity to many microbial infections depends on the phagocytosis of 
invading bacteria by specialised phagocytes (Macrophages, DCs and neutrophils) into a 
plasma membrane derived intracellular vacuole or phagosome. The resulting 
phagosomes then undergo a series of fission and fusion events that modify the 
composition of the limiting membrane and their contents by a sequence that resembles 
the progression of the endocytic pathway. This process is termed phagosome 
maturation.  
Immediately after phagosome formation, the limiting membrane of the phagosome 
resembles the plasma membrane. Recently proteomic analysis of latex bead containing 
phagosomes has identified endoplasmic reticulum being another source of membrane, 
but this proposal is still under debate (Gagnon et al., 2002); (Desjardins, 2003); (Touret 
et al., 2005). As such the phagosome does not evince bactericidal activity. It undergoes 
a complete overhaul, resulting in massive changes in its composition due to a 
progressive maturation process. This process depends critically on the interaction of the 
phagosome with the endocytic pathway; which is a continuum of organelles ranging 
from early endosomes (EE) to lysosomes. Phagosomes undergo transient fusion/fission 
events with the organelles of the endocytic pathway, which are accompanied by 
selective transfer of tracers from the lumen of endosomes to phagosomes. These 
observations have led to the proposal of a “kiss and run” hypothesis (Desjardins, 1995).   
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The first endocytic organelle phagosomes engage with is the EE or the sorting 
endosomes (SE). Several studies indicate that the early phagosomes and EE coalesce. 
These vacuoles are often tubulovesicular and can be typically recognised by the 
presence of Rab5 GTPase, early endosomal antigen 1 (EEA1) and transferin receptors 
(Tfr). The lumen of EE is relatively poor in proteases and is mildly acidic with a pH of 
6.0. From EE or SE cargo can be either sorted out to the recycling endosomes 
earmarked by the presence of Rab11 GTPase or to the late endosome (LE). Killing of 
pathogens and MHCII presentation of antigens to T-cells can be accomplished only if 
the cargo is sorted to the late phagosomes which resemble the LE. These LEs are more 
acidic with a pH of 5.5 and are comparatively enriched in hydrolytic enzymes. LEs can 
be identified by their multivesicular nature, the presence of Rab7 GTPase, Rab9 
GTPase, lysobisphosphatidic acid and lysosome associated membrane protein (LAMP) 
(Vieira et al., 2002). Rab7 is considered vital for the interaction of phagosomes with LE 
by associating itself with dynein-dynactin (microtubule associated motor complex), 
through Rab7 interacting lysosomal protein (RILP). The motors promote the extension 
of tubules towards the late endocytic compartment (Jordens et al., 2001). The final stage 
in the phagosomal degradation pathway is the formation of phagolysosomes by fusing 
with lysosomes. The lysosomes contain the bulk of the proteases and lipases and are 
extremely acidic (pH < 5.5). Lysosomes contain LAMPs and hydrolytic enzymes such 
as cathepsin-D, β-galactosidase etc. These enzymes facilitate the degradation of the 
pathogen and in the loading of peptides on to MHCII. NADPH oxidase also assembles 
in the phagosomes catalysing the formation of reactive oxygen intermediates. It also 
contributes an optimal environment for the activation of proteases. Due to different 
stages PM appears as a complex biological process that is nevertheless performed 
elegantly (Vieira et al., 2002). 
1.2.2 Methods to Study Phagosome Maturation 
Different stages of phagosome maturation have been analysed by investigating the 
proteins that are present on the phagosome/endosome. As described earlier (1.2.1), each 
stage is marked by the presence of different Rab GTPases. Therefore, Rab GTPases can 
be used as markers to study PM (Deretic et al., 1997).  PM has been studied on isolated 
phagosomes of infected phagocytes, using autoradiography and western blot analysis. 
However, fluorescence microscopy is at the present time, probably the most widely 
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used imaging technique to study association of stage-specific proteins with the 
phagosomes/endosome, as it enables the molecular composition of the structures being 
observed to be identified through the use of fluorescently-labelled probes of high 
chemical specificity such as antibodies. These bind stably and specifically to their 
corresponding antigen, they are invaluable as probes for identifying a particular 
molecule in cells, tissues or biological fluids.  Antibody molecules can be used to locate 
their target molecules accurately in cells. When the primary antibody itself or the 
secondary anti-immunoglobulin antibody is labelled with a fluorescent dye the 
technique is known as immunoflurescence microscopy. However, use of antibodies is 
mainly confined to studies of fixed specimens because of the difficulties of introducing 
antibody complexes into living specimens. Non-specific binding of antibodies to 
different proteins of the cell is also possible, which can mislead the investigator. For 
proteins that can be extracted and purified in reasonable amounts, these difficulties can 
be circumvented by directly conjugating a fluorophore to a protein and introducing this 
back into a cell. It is assumed that the fluorescent analogue behaves like the native 
protein and can therefore serve to reveal the distribution and behaviour of this protein in 
the cell. 
An exciting new development in the use of fluorescent probes for biological studies has 
been the development of the use of naturally fluorescent proteins as fluorescent probes. 
The jellyfish Aequorea victoria produces a naturally fluorescent protein known as green 
fluorescent protein (GFP). The gene for this protein has been cloned and can be 
transfected into other organisms. This can provide a very powerful tool for localizing 
regions in which a particular gene is expressed in an organism, or in identifying the 
location of a particular protein. Surprisingly, in many cases these chimeric proteins 
preserve their original function. It is therefore often possible to use this technique to 
visualize the intracellular distribution of a protein. An outstanding advantage of the 
GFP technique is that living, unstained samples can also be observed. There are 
presently several variants of GFP which provide spectrally separable emission colours 
(Heim and Tsien, 1996). 
Gene delivery into primary macrophages is a major hurdle in the use of GFP-fusion 
proteins to study protein distribution in these cells. As they are terminally differentiated 
cells and do not divide, retroviral vectors fail to transfect efficiently (Haddada et al., 
1993). Hence PM has not been studied using protein markers fused to fluorescent 
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proteins in primary macrophages. A better transfection protocol would greatly enable 
researchers to study PM in primary phagocytes.  
1.2.3 Intracellular Signals Targeted by Virulent Mycobacteria to Inhibit 
Phagosome Maturation 
The fact that pathogenic mycobacteria dwell in a hostile environment of the 
macrophages, occupying a naive phagosomal compartment and avoiding the default 
pathway of phagosome maturation was first demonstrated by Armstrong and Hart using 
tracers that end up in the phagolysosomes (Armstrong and Hart, 1975). Phagocytosis of 
mycobacteria involves multiple receptors. The mode of entry has been considered to 
predetermine the subsequent fate of mycobacteria. Mycobacteria opsonised with 
specific antibodies and taken up via Fcγ receptors end up in phagolysosomes. However, 
experiments blocking individual receptors did not show differential trafficking.  Early 
studies have defined the markers of phagosomes containing mycobacteria. Table: 1 
gives a detailed compilation of proteins and lipids studied till date. The most salient 
features of  mycobacterial phagosomes are that they fail to acidify below pH 6.2 and are 
characterised by the absence of lysosomal associated membrane proteins (LAMP), 
lysosomal hydrolases, reduced levels of ATPase and retention of early endosomal 
markers Rab5 (Russell, 2001); (Via et al., 1997).  Phagosomes containing mycobacteria 
were found to tether TACO or mouse coronin. This was thought to be a reason for the 
defective PM. Other independent groups either found coronin insufficient to halt 
mycobacterial phagosomes from maturing or could not confirm the role of coronin. 
Recent studies indicate that mycobacteria effectively arrest phagolysosomal biogenesis 
by suppressing sphingosine 1-phosphate regulated cytosolic Ca2+ rise ((Malik et al., 
2001); (Malik et al., 2003)), which in turn hinders recruitment of Phosphoinositol-3-
kinase (PI3K) or yeast hVPS34 to the phagosomal membrane. Aberrant mustering of 
hVPS34 inhibits tethering of EEA-1 or Hepatocyte growth factor-regulated tyrosine 
kinase substrate (Hrs) to the mycobacterial phagosome (MP), leading to an obstruction 
in the delivery of lysosomal ingredients from trans golgi network to the MP (Deretic et 
al., 2004). Actin is an important factor that mediates the fusion of phagosomes with the 
organelles of the endocytic pathway. Pathogenic mycobacteria are capable of disrupting 
the actin filament network surrounding the mycobacterial phagosome (Guerin and de 
Chastellier, 2000). This disruption of actin nucleation surrounding the MP has been 
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observed to be complemented by the addition of selected lipids (arachidonic acid, 
phosphoinositol-4,5-bisphosphate (PtdIns(4,5)P2), ceramide, sphingosine and 
sphingosine-1-phosphate) at low and high ATP concentrations. Another important 
molecule in PM is cAMP. Levels of cAMP in phagosomes are regulated by protein 
kinaseA (PknA). Lowering cAMP or inhibiting PknA leads to increased actin 
nucleation and phagosome-lysosome fusion and thereby increased killing of pathogenic 
mycobacteria (Kalamidas et al., 2006).   M. avium and Mtb containing phagosomes also 
become gradually depleted for selective cell surface derived glycoproteins and probably 
mycobacteria themselves revert back to reside in immature phagosomes from 
phagolysosome (Pietersen et al., 2004). Mycobacteria thus target multiple signalling 
events in a disciplined fashion using their complex machinery. Understanding the 
armoury used by mycobacteria to prevent PM is imperative in designing new 
therapeutics or vaccines to tackle TB.  
Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
Maturation markers 
Cathepsin D + +a Lysosomal hydrolase (Sturgill-Koszycki et al., 1996) 
CD63 (LIMP-1) + − Lysosomal marker (Clemens and Horwitz, 1995) 
V1 H+ATPase (E 
subunit) 
+ − Head group of vacuolar 
H+ATPase (ATP 
hydrolysis), acidification of 
phagosome 
(Sturgill-Koszycki et al., 1994) 
Vo H+ ATPase (16-
kDa proteolipid; 
110-kDa accessory 
protein) 
+ − Transmembrane portion of 
vacuolar H+ATPase (H+ 
translocation), acidification 
of phagosome 
(Fratti et al., 2003b); (Sturgill-
Koszycki et al., 1996) 
LAMP-1, LAMP-2 + +/−b Lysosomal markers (Clemens and Horwitz, 1995); (Xu 
et al., 1994) 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
Mannose 6 
phosphate receptor  
+ − Lysosomal hydrolase 
trafficking 
(Xu et al., 1994); (Barker et al., 
1997) 
Transferrin receptor 
(TfR) and 
transferrin 
+c +c Recycling endosome 
markers and iron delivery 
(Clemens and Horwitz, 1996); 
(Sturgill-Koszycki et al., 1996); (Via 
et al., 1997); (Kelley and Schorey, 
2003) 
Small GTP-binding proteins 
ARF6 +c +c Endosomal trafficking, 
actin remodeling, cell 
shape 
(Niedergang et al., 2003) 
LRG-47 +d +d Specifically induced by 
IFNγ 
(MacMicking et al., 2003) 
Rab2 +e ND ER to golgi traffic (Garin et al., 2001) 
Rab4 −e,f,g −e,f Recycling endosome, fast 
recycling 
(Garin et al., 2001), (Via et al., 
1997)f 
Rab3c +e ND Unknown (Garin et al., 2001) 
Rab5 +h +h Early endosome fusion (Via et al., 1997) 
Rab7 + − Late endosome transport (Via et al., 1997) 
Rab9 +f −f Late endosome to TGN 
retrograde transport 
(Fratti et al., 2003b); (J. Chua et al., 
unpublished data)f 
Rab10 +e,f +f Unknown (Garin et al., 2001)f 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
Rab11a + + Recycling endosome (Fratti et al., 2003b) 
Rab11b +e ND Recycling endosome (Garin et al., 2001) 
Rab14 +e,f,i +f,i Unknown (Garin et al., 2001); (J. Chua et 
al.,unpublished data)f 
Rab22 +f,i +f,i Unknown (J. Chua et al., unpublished data)f 
Rab interacting proteins 
Guanine nucleotide 
dissociation 
inhibitor (GDI) 
− + Maintains Rab5 in GDP-
bound (inactive) form 
(Fratti et al., 2003a) 
EEA1 + − Early endosome tethering 
molecule 
(Fratti et al., 2001) 
Rabaptin-5 − − Rab5 effector (Fratti et al., 2001) 
Rab7-interacting 
lysosomal protein 
(RILP) 
+j ND Dynein motor endosomal 
movement 
(Harrison et al., 2003) 
SNAREs and interacting proteins 
Cellubrevin +k +k Recycling endosome v-
SNARE 
(Fratti et al., 2002) 
Endobrevin + + Recycling endosome v-
SNARE 
(R.A. Fratti et al., unpublished data)
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
N-ethylmaleimide-
sensitive fusion 
protein (NSF) 
+ + ATPase essential for 
membrane fusion 
(Fratti et al., 2002) 
alpha-soluble NSF 
attachment protein 
(αSNAP) 
+ + NSF adaptor essential for 
membrane fusion 
(Fratti et al., 2002) 
SNAP23 + + Plasma membrane, early 
endosome t-SNARE 
(Fratti et al., 2002) 
Syntaxin 3 + + Plasma membrane t-
SNARE 
(Fratti et al., 2003b) 
Syntaxin 4 +c +c Plasma membrane and 
endosome t-SNARE 
(Vergne et al., 2004b); (R.A. Fratti 
et al., unpublished data) 
Syntaxin 6 + − TGN t-SNARE (Fratti et al., 2003b) 
Syntaxin 7 + + Late endosome t-SNARE (Defacque et al., 2000); (R.A. 
Frattiet al., unpublished data) 
Syntaxin 8 + + Early endosome, late 
endosome t-SNARE 
(Fratti et al., 2003b) 
Syntaxin 13 + + Early endosome t-SNARE (Fratti et al., 2001), (Defacque et 
al., 2000) 
 
Cytoskeleton proteins and motors 
Actin +e − Microfilaments (Anes et al., 2003), (Garin et al., 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
2001) 
Annexins +l +/−l Unknown (Diakonova et al., 1997), (Pittis et 
al., 2003) 
Coronin/TACO +m +m Actin-binding protein 
participating in 
phagocytosis 
(Pieters, 2001)n; (Tailleux et al., 
2003) 
Dynein and 
dynactin 
+ ND Microtubule motor (Blocker et al., 1997) 
Ezrin/moesin + ND Actin assembly (Defacque et al., 2000) 
Kinesin + ND Microtubule motor (Blocker et al., 1997) 
Myosins + ND Actin motor (Al-Haddad et al., 2001) 
Tubulin +e ND Microtubules (Garin et al., 2001) 
Signaling proteins 
Calmodulin +n − Ca2+-binding sensor (Malik et al., 2001) 
CaMKII/Phospho 
CaMKII 
+n − Calmodulin effector 
protein kinase 
(Malik et al., 2001) 
 
 
Lipids and lipid modifying enzymes 
Cholesterol ND +o Lipid rafts (Gatfield and Pieters, 2000) 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
Diacylglycerol 
(DAG) 
+j ND Signaling lipid on plasma 
membrane 
(Botelho et al., 2000) 
Lysobisphosphatidi
c acid (LBPA) 
+ − Late endosome, 
multivesicular bodies 
(Fratti et al., 2001), (Fratti et al., 
2003a) 
Phosphatidylinositol 
3-phosphate (PI3P) 
+p +/−p Signaling lipid on 
endosomes 
(Vieira et al., 2001); (J. Chua et al., 
unpublished data)p 
Phosphatidylinositol 
4-phosphate (PI4P) 
−f −f Precursor of PI(4,5)P2 (J. Chua et al., unpublished data)f 
Phosphatidylinositol 
4,5-bisphosphate 
(PI(4,5)P2)Z 
+f,q +f,q Signaling lipid on plasma 
membrane 
(Botelho et al., 2000); (J. Chua et 
al., unpublished data)f 
Phosphatidylinositol 
3,4,5-trisphosphate 
(PI(3,4,5)P2) 
+f,q,r +f,q,r Signaling lipid on plasma 
membrane 
(Marshall et al., 2001); (J. Chua et 
al., unpublished data)f,r 
MTM1 − − PI3P phosphatase (J. Chua et al., unpublished data)f 
MTMR3 + + PI3P phosphatase (J. Chua et al., unpublished data)f 
Phosphatidylinositol 
3-Kinase (p85 unit), 
Type I 
+j,q ND Regulatory subunit, 
synthesis of PI(3,4,5)P3 
(Marshall et al., 2001) 
Phosphatidylinositol 
3-Kinase (hVPS34), 
Type III 
+s +s Catalytic subunit, 
synthesis of PI3P 
(Fratti et al., 2001),(Vieira et al., 
2001) 
Phosphatidylinositol 
phosphate kinase 
+j,q ND Synthesis of PI(4,5)P2 (Botelho et al., 2000) 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
(PIKIα), Type I 
Phospholipase C 
(PLCγ) 
+j,q ND Signaling enzyme 
recruited to the plasma 
membrane 
(Botelho et al., 2000) 
PTEN −j ND Terminates PI(3,4,5)P3 
signal, produces PI(4,5)P2
(Marshall et al., 2001) 
SHIP1 +j,q ND Terminate PI(3,4,5)P3 
signal, produces PI(3,4)P2
(Marshall et al., 2001) 
Biosynthetic pathway 
Calnexin + + ER chaperone (Gagnon et al., 2002), (Tailleux et 
al., 2003) 
Calreticulin +t ND ER chaperone (Gagnon et al., 2002), (Henry et al., 
2004))t 
Sphingomyelin + − Sphingolipid made in 
Golgi 
(Fratti et al., 2003b) 
Antigen presentation and recognition 
CD1a, b, and c +u +u Lipid antigen presentation (Schaible et al., 2000) 
MHC class I +/−v +/−v Cytosolic antigen 
presentation 
(Clemens and Horwitz, 1995) 
MHC class II +/−v +/−v Endosomal antigen 
presentation 
(Clemens and Horwitz, 1995), 
(Ullrich et al., 2000) 
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Table 1  Regulators of membrane trafficking and maturation markers on mycobacterial phagosomes 
Protein or lipid 
Latex Bead 
phagosome 
Mycobacter
Phagosome
Cellular function or 
location References 
Toll-like receptors 
(TLR) 
+ ND Pathogen-associated 
molecular patterns 
recognition and initiation 
of innate immune 
responses 
(Underhill et al., 1999)  
aImmature intermediate form. 
bVariable results. 
cSyntaxin 4, ARF6, and TfR accumulate on mycobacteria phagosomes, whereas they are transiently 
present on latex bead phagosomes. 
dLRG-47 expression is induced in IFNγ-activated macrophages. 
eProteomic analysis of purified latex bead phagosomal preparations (Garin et al., 2001). 
fTime-lapse 4D confocal microscopy with GFP fusion protein in RAW-transfected cells. 
gRab4 was not detected on mycobacteria and latex bead phagosomes by Western blot on isolated 
phagosomes (Via et al., 1997). However, it was detected on latex bead phagosomes using a 
proteomic approach (Garin et al., 2001). 
hRab5 accumulates on mycobacterium phagosomes but not on latex bead phagosomes. 
iDifferent dynamics between latex bead and mycobacterium phagosomes. 
jIgG-opsonized 3-μm beads used for model phagosome (instead of 1-μm beads). 
kCellubrevin is present on both mycobacteria and latex bead phagosomes, but a putative degradation 
product is present on mycobacteria phagosomes. 
lLess annexin I, VI, VII, and XI on mycobacteria phagosomes than on latex bead phagosomes. 
mCoronin, termed TACO by Pieters and colleagues, appears to be selectively accumulated on 
mycobacterial phagosomes (Pieters, 2001). 
nDead mycobacteria used for model phagosome (instead of 1-μm latex beads). 
oCholesterol enrichment during mycobacteria entry into macrophages. 
pTime-lapse confocal microscopy with GFP fusion protein probe for PI3P in RAW-transfected cells. 
Different dynamic and profiles between 1-μm latex bead and mycobacteria phagosomes (J. Chua et 
al., unpublished data). 
qPresent on phagocytic cups but absent upon completion of the phagosomal closure. 
rPI(3,4,5) P3 is present on phagocytic cups of mycobacteria and IgG-opsonized 3-μm beads but not on 
complement-opsonised 1-μm bead phagosomes. 
sWestern blot of isolated phagosomes shows that hVPS34 is present on latex bead and mycobacteria 
phagosomes but at different time points. 
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tYFP-tagged ER targeting and retrieval sequence of calreticulin failed to colocalize with erythrocyte 
phagosomes (Henry et al., 2004). 
uCD1a and c are found on mycobacterial phagosomes, whereas CD1b is found only on 
phagolysosomes. 
vDifferent profiles depending on the macrophages (human versus murine and resting versus IFNγ-
activated). 
Adapted from (Vergne et al., 2004a) 
1.3 Genetic Tools to Study Mycobacterial Virulence Factors 
The first condition of Koch’s molecular postulates was to isolate a mutant bacterium 
with a phenotype that differs from wild-type phenotype. This postulate was fulfilled 
with the isolation of BCG (bacillus Calmette-Guèrin) by Calmette and Guèrin in 1908. 
To prove that a phenotype such as virulence is caused by the presence and expression of 
specific gene, it is necessary to (i) isolate a mutant bacterium with a phenotype that 
differs from the wild-type phenotype, (ii) to clone the wild-type gene and (iii) by 
introducing the wild-type gene back into the mutant bacterium, to reproduce the wild-
type phenotype. These points have been considered by molecular biologists as Koch’s 
molecular postulates. Methods to fulfil molecular postulates of Koch, namely to clone 
the wild-type gene and introducing the wild-type gene back into the mutant bacterium, 
to reproduce the wild-type phenotype were not possible until quite recently.  Unique 
characteristics of mycobacteria like that of its slow growth rate and unusually rich lipid 
cell envelope were major obstacles in the development of genetic methodologies to 
study this organism (Jacobs and Bloom, 1994).  
Approaches for studying mycobacterial pathogenesis include (a) analysis of 
mycobacterial gene expression under specific growth  and environmental conditions, (b) 
the use of information derived from genome determinations to identify homologues of 
virulence genes of other organisms, (c) generation of mutations in specific genes 
hypothesised to be involved in pathogenesis and comparison of intracellular survival 
and growth between mutant and wild-type strains, and (d) screening of libraries of 
randomly generated mutants for altered ability to survive and grow intracellularly.  
1.3.1 Gene Expression Analysis  
In past years studies on mycobacterial gene expression during its growth in different 
environments have augmented our understanding of mycobacterial physiology. Many of 
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these studies have been performed on mycobacteria grown under in vitro conditions 
designed to simulate in vivo situations. However, advancements in molecular biological 
techniques have enabled investigators to use animals or human cells in culture to 
analyze in vivo gene expression.  
Investigators have used complementary DNA (cDNA) subtractive hybridization to 
identify genes differentially expressed by bacteria grown in various environments or 
closely related bacterial species. This method subtracts out common cDNA molecules 
and leaves cDNA molecules corresponding to genes that are differentially expressed or 
uniquely expressed by mycobacteria in a specific environment. cDNA-RNA subtractive 
hybridization was used to identify differentially expressed genes by comparing 
messenger RNA (mRNA) levels in virulent Mtb strain (H37Rv) with that of an avirulent 
Mtb strain (H37Ra) (Kinger and Tyagi, 1993). In another study, cDNA-cDNA 
subtractive hybridization was used to compare differential gene expression patterns of 
M. avium grown in macrophages compared to that of M. avium grown in broth. This is 
the only published study in which c-DNA subtractive hybridization was performed on 
cultured primary macrophages (Plum and Clark-Curtiss, 1994). Selective capture of 
transcribed sequences, an improvement of c-DNA subtractive hybridization was 
developed for analysing bacterial gene expression during growth in HMDM (Graham 
and Clark-Curtiss, 1999). This technique was also used to study the genes expressed by 
Mtb and M. avium in common that are important for survival and growth in HMDM 
(Hou et al., 2002). 
Another approach for identifying genes that are differentially expressed in specific 
environments has been the generation of libraries of DNA fragments cloned into 
plasmids upstream of a promoterless reporter gene. The principle of this assay is that 
some of the clones in the library will possess promoter sequences which can be induced 
in response to specific environmental conditions resulting in the expression of the 
reporter gene. The reporter gene should encode a product which is stable and easy to 
assay in mycobacteria. Reporter genes namely, cat, lacZ, phoA and xylE have been used 
by different groups (Kinger and Tyagi, 1993). More recently gene encoding GFP has 
been extensively used by several groups to assess induction of the respective genes in 
response to various environmental conditions. In contrast to other reporter genes, GFP 
does not require the addition of substrates or cofactors, thus allowing this reporter to be 
used when studying live bacteria.  In addition to facilitating studies on broth grown 
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bacteria, GFP reporter systems have been used to study gene expression in 
mycobacteria growing in cultured cells and in animal tissues. A GFP reporter system 
was also used in promoter trap libraries of M. marinum DNA fragments, leading to the 
identification of virulent genes expressed specifically in granulomas (Ramakrishnan et 
al., 2000). 
The most desirable way to assess gene expression in Mtb growing in a specific 
environment would be to analyse every possible ORF in the genome. This capability is 
the premise and the promise of DNA microarray analysis (Clark-Curtiss and Haydel, 
2003). These microarray based studies typically use expression data to make inferences 
about the biological functions of regulated genes – a strategy proven to be fruitful in 
other organisms. Most microarray based mycobacterial studies have focused on in vitro 
conditions thought to mimic infections (i.e. starvation, iron limitation, exposure to nitric 
oxide or hypoxia (Betts et al., 2002); (Ohno et al., 2003); (Hampshire et al., 2004); 
(Bacon et al., 2004). DNA microarray analyisis for studying mycobacterial gene 
expression in vivo is technically challenging due to the requirement of large amounts of 
total RNA in order to generate cDNA probes. However, a few groups have succeeded in 
overcoming technical hurdles, enabling comprehensive analysis of genes expressed in 
vivo. Mtb expression patterns in the context of macrophage were first examined by 
Schnappinger and colleagues (Schnappinger et al., 2003). More recently the 
transcriptome signature of Mtb in human pulmonary tuberculosis was elegantly studied 
on clinical lung samples using DNA microarray analysis (Rachman et al., 2006). 
Although gene expression studies are of value and interest, there are important 
limitations in the design and interpretation of expression experiments. (i) These studies 
represent snapshots in time. Altering the expression of a gene might have consequences 
at a much later point during the course of infection. (ii) Transcriptional changes in a 
gene could be responses to a variety of stimuli. (iii) Although the upregulation of a gene 
might suggest an important role in infection, this is certainly not always true. Therefore 
complementary approaches are needed to dissect the roles of individual genes (Murry 
and Rubin, 2005). 
1.3.2 Comparative Genomics 
Determination of the complete nucleotide sequence of Mtb H37Rv (Cole et al., 1998), 
Mtb CDC1551, M. avium (http://www.tigr.org), M. bovis, M. marinum 
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(http://www.sanger.ac.uk) and M. leprae (Cole et al., 2001) genomes has provided a 
means to compare these genomes and has revealed features of the genomes that were 
previously unknown. Comparison of genomes has also provided information that should 
be useful for further understanding of the basis for attenuation of strains such as Mtb 
H37Ra and M. bovis BCG. By identifying sequences that have been deleted or disrupted 
in the attenuated strains and the subsequent knock out of specific genes in these 
sequences in wild-type Mtb or M. bovis or introducing these genes into the attenuated 
strains, investigators were able to evaluate the contributions of specific genes to 
virulence (Clark-Curtiss and Haydel, 2003). Recent work has suggested that strain 
comparisons will continue to yield significant insights into pathogenesis. Genomic 
deletions and alterations are likely to be present in most clinical strains and there are 
evidences that these alterations might affect the severity of the disease outcome (Kato-
Maeda et al., 2001a; Kato-Maeda et al., 2001b); (Tsolaki et al., 2004). Studies have 
been carried out to show that some strains, such as the Texas HN878 strain, as well as 
several other Beijing strains, kill mice more rapidly than the sequenced reference strains 
(Manca et al., 1999); (Lopez et al., 2003). These results complement epidemiological 
evidence, supporting the increased prevalence of Beijing strains (Glynn et al., 2002).  
Although strain variability has important biological consequences, limited knowledge is 
available on the mechanisms of pathogenesis that are common to all strains.  Analysis 
of variation has limited ability to illuminate shared characteristics (Murry and Rubin, 
2005). 
1.3.3 Generation of Mutations in Specific Genes 
The tubercle bacillus has been extremely successful at holding its own virulence secrets 
hostage. However, development of several efficient mutagenesis strategies has greatly 
assisted in identifying Mtb virulence factors. In order to decipher the roles of genes 
identified through gene expression analysis or comparative genomics approach, 
candidate genes have to be mutated as a complementary approach.  
Targeted knock out of specific genes in mycobacteria has been achieved by using linear 
substrates, counterselectable plasmid delivery systems and phage delivery systems. 
Earlier long linear substrate: ∼ 20 kb of homologous flanking DNA was used to create a 
mutant. More recently, allelic exchange mutants have been created by electroporating 
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short, linear plasmids harbouring the respective genes interrupted by Kanamycin or 
Hygromycin resistant markers (Clark-Curtiss and Haydel, 2003). Counterselectable 
plasmid delivery systems have greatly improved the efficiency of isolating targeted 
mutations in mycobacteria. The most common allelic exchange mutagenesis procedure 
currently being used with mycobacteria involves a two-step selection method 
employing the counterselectable properties of the sacB gene, which is lethal to 
mycobacteria in the presence of sucrose (Pelicic et al., 1996a, 1996b). After the first 
selection on an antibiotic containing solid medium, clones are propagated in liquid 
medium to facilitate second crossover needed for allelic exchange followed by selection 
on sucrose. This procedure has been used extensively to generate numerous mutants.  
The development of conditionally replicating mycobacteriophages provides another 
genetic strategy to generate targeted deletion mutations via allelic exchange. The 
mycobacteriophage delivery system involves the use of temperature-sensitive shuttle 
phasmids that can replicate as plasmids in E. coli and as phages in mycobacteria. These 
phasmids are able to infect and replicate as phage particles in M. smegmatis at 30°C 
(permissive temperature), but fail to replicate in bacterial host cells (e.g. Mtb) at the 
nonpermissive temperatures, 37°C (TM4-based) or 38.5°C (D29-based), thereby 
allowing transposon delivery or generation of defined deletion mutations by allelic 
exchange (Bardarov et al., 1997). 
1.3.4 Analysis of Mutant Library 
Transposon mutagenesis is a procedure that generates stable, single insertions which 
can be subsequently linked to the disrupted gene. Transposon mutagenesis is achieved 
by using a transposon, a DNA element that can move from its original site on a DNA 
molecule to a random site in the same or different DNA molecule. The transposition 
event, i.e., the transfer of the transposon from one site to another is mediated by a gene 
encoding for transposase. In addition to carrying the transposase, the transposon carries 
a selectable marker gene, such as an antibiotic resistance gene. Thus to generate a 
library of transposon-inserted mutants, the transposon is introduced into the host 
bacterium by means of a delivery vector that cannot replicate in the host organism. The 
transposon will hop from the delivery vector to the chromosome of the host bacterium. 
The bacterial cells in which the delivery vector is introduced are plated on medium 
containing selective agent. Only those cells in which the transposon has stably inserted 
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will give rise to colonies. By collecting large sets of colonies from such an experiment, 
a library of transposon mutants can be assembled. Because transposon-mediated 
mutagenesis can potentially allow for insertions in every gene of a bacterial 
chromosome, transposon mycobacterial mutant libraries have been constructed in 
different mycobacterial strains and species. Several advances in molecular 
mycobacteriology have enabled analysis of multiple mutants rather than performing 
individual experiments with each mutant.  
Signature tagged mutagenesis (STM) marked a new era in the generation of transposon 
mutant libraries and in the subsequent screening of bacterial virulence gene mutants in 
appropriate animal models. This novel system uses a pool of uniquely oligonucleotide-
tagged transposons for mutagenesis, thus allowing individual transposons to be 
identified by hybridization to the signature oligonucleotide tag after insertion into the 
genome. Therefore, pools of mutants can be used to infect animals in an effort to 
identify strains with attenuated virulence. STM has been successfully used to identify 
numerous virulence genes in numerous pathogens including Mtb (Clark-Curtiss and 
Haydel, 2003). 
Additional approaches DeADMAn (Designer arrays for defined mutant analysis) and 
TraSH (transposon site hybridization) for screening transposon pools have been recently 
developed. These methods rely on microarray hybridization for the analysis of mutant 
abundance, which provides a more quantitative approach than radiolabelling used by 
STM. All these screens have been so far employed to study genes involved in the fitness 
of mycobacteria in the host. They use a very narrow definition of virulence. These 
screens identify genes that are required for bacterial survival and growth in the host. 
Survival and growth, though necessary to cause disease, are by no means the only 
functions associated with causing it (Murry and Rubin, 2005). Specific screens to 
identify virulent genes involved in arresting PM in macrophages, which is considered 
central for the TB pathogenesis, will greatly assist in understanding the virulence 
mechanisms of mycobacteria. 
1.4  Mycobacterial Factors Disrupting Phagosome Maturation 
Though several host cell mechanisms in the inhibition of phagosome maturation have 
been proposed, the explanation of how mycobacteria accomplish a safe haven for 
themselves in the macrophages remains elusive. Generating genetic tools to study 
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mycobacteria have lead to identification of virulence factors involved in the inhibition 
of PM. Early studies by Goren and colleagues have shown that Mtb uses its sulphur-
containing-lipid to inhibit PM (Goren et al., 1976), but this was later attributed to a 
technical problem. Cord factor or trehalose dimycolate (TDM) a characteristic lipid of 
Mtb caused a delay in phagosomal acidification (Indrigo et al., 2003). Phosphoinositols 
are part of another mycobacterial lipid family which includes lipoarabinomanan (LAM) 
and phosphoinositol mannoside (PIM). Phagocytised LAM coated beads have similar 
properties as that of MP, including reduced acidification and reduced acquisition of late 
endosomal markers. LAM also inhibits PI3kinase dependent pathway between TGN 
and phagosomes. LAM also prevents the recruitment of EEA-1 another important factor 
in PM. Improper recruitment of EEA-1 leads to reduced Ca2+ flux (Vergne et al., 
2003). This explains in part the mycobacterial inhibition of Ca2+/calmodulin complex 
as shown by Kusner and colleagues (Malik et al., 2001; Malik et al., 2003). 
Phosphoinositol mannosides (PIM) are similar to the mammalian phosphoinositol lipids 
and hence preferentially enhance fusion of MPs with early endosomes by competing 
with phosphoinositol-3-phosphate (PI3P) (Vergne et al., 2004b). Studies have also 
postulated possible roles for mycobacterial urease (Gordon et al., 1980). In addition, a 
secreted mycobacterial lipid phosphatase (SapM) was identified by Vergne and 
colleagues which is held responsible for hydrolyzing PI3P, leading to inhibition of PM 
(Vergne et al., 2005).  Eukaryotic-like serine/threonine mycobacterial protein kinase G 
is said to prevent transfer of mycobacteria to lysosomes, suggesting that virulent 
mycobacteria have evolved eukaryotic-like signal transduction mechanisms (Walburger 
et al., 2004). It is reasoned that close apposition of mycobacteria to the phagosomal 
membrane hampers MP maturation (de Chastellier and Thilo, 1998). This concept was 
expanded by the observation that cholesterol depletion with methyl-β-cyclodextrin 
loosened the close apposition of phagosomal membrane and bacterium and resulted in 
fusion with lysosomes (de Chastellier and Thilo, 2006). ESAT-6 and CFP-10 might also 
have additional roles in inhibiting PM as evinced from studies conducted using M. 
marinum (Tan et al., 2006). Discrepancies arising from different groups and recent 
screens to identify genes involved in the inhibition of PM suggest involvement of more 
than one effector molecule in the retardation of MP maturation (Pethe et al., 2004); 
(Stewart et al., 2005). Most of the studies emphasise the participation of the 
mycobacterial cell envelope lipids in the inhibition of PM. 
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1.5 Unique Cell Envelope and Lipids of Mycobacteria 
Mycobacteria are a family of eubacteria that belong to a group of Gram-positive 
bacteria containing GC-rich DNA (Cole et al., 1998). These bacteria produce cell walls 
of a unique structure, containing meso-diaminopimelic acid as the diamino acid in the 
peptidoglycan. Interestingly the muramic acid residue is N-glycosylated in 
mycobacterium, in contrast to the N-acetlyation found in most other bacteria. An 
important feature of the cell wall is the presence of a unique polysaccharide, 
arabinogalactan (AG), which is substituted by characteristic long chain fatty acids, 
namely the mycolic acids containing 70-90 carbon atoms (Brennan and Nikaido, 1995).  
Mycolic acids 
Mycolic acids are high molecular weight α-alkyl, β-hydroxy fatty acids. They primarily 
appear as esters of AG, but are also in extractable lipids namely as trehalose 6-6’- 
dimycolate (TDM or cord factor). Mycolic acid structures can be separated into 
meromycolate moiety and the α-branch. They have the largest α-branch (C20 to C25). In 
the main chain (the meromycolic acid moiety), they contain one or two groups which 
may be double bonds or cyclopropane rings that are capable of producing "kinks" in the 
molecule; they may contain oxygen functions additional to the β-hydroxy group; and 
they may have methyl branches in the main carbon backbone (Fig: 1). The 
cyclopropane rings in the meromycolate chain are mediated by specific methyl 
transferases (Barry et al., 1998); (Glickman et al., 2000). Knocking out the genes 
coding for these methyltransferases leads to loss of oxygenated mycolic acids and 
cyclopropanation on major mycolic acids, difference in colony morphology and reduced 
virulence (Dubnau et al., 2000); (Glickman et al., 2000). These observations also 
implicate the fine structure of mycolic acid subclasses in the interaction of mycobacteria 
with the host immune system. 
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Fig1: Structure of mycolic acids from mycobacteria adapted from (Brennan and Nikaido, 1995) 
Lipoarabinomanan (LAM) 
Mycobacteria also contain soluble immunologically active arabinomanan (Azuma et al., 
1970). Studies showed that LAM contains glycerol, inositol and phosphate in addition 
to arabinose, mannose, lactate, succinate, palmitate and tuberculostearate, which were 
identified much earlier (Hunter and Brennan, 1990). LAM is a multiglycosylated 
extension of PIMs. The arabinose termini of LAM from Mtb is capped with mannose 
residues and termed as mannose lipoarabinomanan (ManLAM) (Chatterjee et al., 1992). 
In contrast, the LAM of the rapidly growing species M. smegmatis is devoid of mannose 
caps and is termed arabinose lipoarabinomanan (AraLAM) (Prinzis et al., 1993). LAM 
exhibits a wide spectrum of immunoregulatory functions. Earlier data using LAM of M. 
leprae and AraLAM from a rapidly growing mycobacterium species were interpreted as 
a suggestion that LAM suppresses immune responses, thus contributing to pathogenesis 
of tuberculosis and leprosy. These data include LAM-induced abrogation of T-cell 
activation (Kaplan et al., 1987), inhibition of γ-interferon mediated activation of murine 
macrophages (Sibley et al., 1988), scavenging of potentially cytotoxic oxygen free 
radicals, and inhibition of protein kinase C activity (Chan et al., 1991). Although 
AraLAM evoked a large array of cytokines associated with macrophages, such as TNF-
α (Chatterjee et al., 1992), granulocyte macrophage colony stimulating factor, and 
interleukins-la, lb, 6, and 10 (Barnes et al., 1992), this was frequently interpreted as a 
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contributor to the disease processes: for example, the production of fever, weight loss, 
and tissue necrosis was emphasized in the case of TNF-α. More recently, however, 
ManLAM, which is present in strains of Mtb, was found to be much less potent in 
evoking TNF-α, in contrast to AraLAM found in non-virulent species (Chatterjee et al., 
1992). Similarly, AraLAM, but not ManLAM, was found to activate the early response 
genes (including c-fos and the genes for TNF-α) in macrophages (Roach et al., 1993). 
Additionally, ManLAM could stimulate phagocytosis by interacting with the Man 
receptor (Schlesinger, 1993). These results now suggest that Mtb strains become 
phagocytised efficiently but survive within the host macrophages because their 
ManLAM does not activate these phagocytes (Brennan and Nikaido, 1995). Moreover, 
recently it was shown that Mtb LAM inhibited cytosolic calcium rise thereby blocking 
the acquisition of late endosomal and lysosomal markers. 
Waxes, Acylated Trehaloses and Sulpholipids 
Several slowly growing mycobacteria contain an array of waxes, generally long-chain 
diols [phthiocerols A and B, phthiodiolone, phthiotriol; phthiocerol A is a mixture of 3-
methoxy-4-methyl-do-(and tetra)-triacontane-9,11-diols] in which long chain fatty acids 
namely mycocerosic acid or its isomer phthioceranic acid are esterified to both hydroxyl 
groups. Three other families of trehalose-based lipids have been implicated in the 
pathogenesis of tuberculosis (Brennan and Nikaido, 1995), (i) cord factor, (ii) the 
simpler acylated trehaloses [containing a combination of saturated straight-chain C16-
C19, C21-C25 mycocerosate, C24-C2s mycolipanolic, and C25-C27 mycolipenic fatty 
acids: for example, 2, 3-di-O acylated trehalose isolated from Mtb, (iii) and  the 
sulfolipids (trehalose 2´-sulfate acylated with hydroxyphthioceranic, phthioceranic, and 
saturated straight-chain fatty acids). The cord factor can produce granulomatous 
inflammation and thymic atrophy when injected into mice (Ozeki et al., 1997) in 
addition to affecting membrane fusion in model systems (Spargo et al., 1991) and 
toxicity for mitochondria (Glickman and Jacobs, 2001). Mutants that failed to produce 
or secrete the phthiocerol containing PDIM (Phthiocerol di mycocerosate) failed to 
replicate in the lungs and were hypothesized to be necessary for organ specific 
replication (Camacho et al., 1999); (Cox et al., 1999). Sulfolipid of Mtb was the first 
lipid to be shown to inhibit PM. Thus, all these waxes are thought to be significant for 
the successful pathogenesis. 
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The Extractable Lipids of Cell Wall 
The search for dominant antigens on the surfaces of various mycobacteria, especially 
"atypical" (or nontuberculous saprophytic) mycobacteria, was stimulated by the 
infections caused by these bacteria in immunocompromised patients (Horsburgh and 
Selik, 1989). This led to the definition of a remarkable army of cell wall glycolipids 
(Brennan, 1989). The major classes of such extractable glycolipids include 
lipooligosaccharides (LOS), phenolic glycolipids (PGLs), and glycopeptidolipids 
(GPLs)  
Members of the LOS class of glycolipids were first found in M. kansasii and later in M. 
malmoense, M. szulgai, M. gordonae, and M. butyricum. They are composed of variable 
residues of xylose, 3-O-methyl rhamnose, fucose and a novel N-acylamino sugar (N-
acylkansosamine) linked to a common tetra glucose core, which itself contains an α,α´-
trehalose moiety at the end (Figure: 2). The terminal glucose residue of the α,α´-
trehalose unit is usually acylated at positions 3, 4, and 6 by 2,4-dimethyl tetra decanoic 
acid residues ("R" in Figure2 ) (Brennan and Nikaido, 1995). Very recently LOS 
biosynthetic gene cluster was identified in M. marinum and it was also shown that LOSs 
play an important role in sliding motility, biofilm formation, and infection of host 
macrophages (Ren et al., 2007). 
Another class of mycobacterial glycolipids are glycopeptidolipids (GPLs) [described as 
"C-mycosides" in earlier literature]. As shown in Figure 5, the head group is a short 
peptide, D-Phe-D-allo Thr-D-Ala-L-alaninol and the alaninol is substituted by a 3, 4-di-
O-methyl-L-rhamnose. The hydroxyl group of the D-allothreonine residue carries an 
oligosaccharide substituent; its most proximal portion is usually α-L-rhamnopyranosyl-
(1-2)-6-deoxy-L-talopyranose. The amino group of D-phenylalanine residue is 
substituted by a fatty acid residue. GPLs are the major cell surface antigens of the M. 
avium, M. intracellulare, M. scrofulaceum group, and they can be subdivided into 31 
distinct serotypes based on the serospecific GPLs. GPL has been suggested to protect 
mycobacterial cells within the phagolysososmes. It is also shown that GPL from M. 
avium serovar 4 inhibits PM whereas GPL from serovar 9 does not inhibit PM. 
Additionally it is also reported that the inhibition is mediated through mannose receptor 
(Shimada et al., 2006).  
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Another class of glycolipids is more correctly termed glycosylphenolphthiocerol 
dimycocerosates, although the term PGL is generally used (Brennan, 1989); (Besra et 
al., 1991); (Dobson et al., 1990); (Gaylord and Brennan, 1987). This class includes 
"mycoside A" of M. kansasii, "mycoside G" of M. marinum, and "mycoside B" of M. 
bovis in the earlier literature. Their structure (Figure: 2) is characterized by a very large 
hydrophobic moiety, containing a C36 phenolic diol substituted by two molecules of 
typically C34 fatty acid, mycocerosate. The oligosaccharide part contains from one to 
four sugar residues, and the sugars are usually not very hydrophilic, often consisting of 
deoxy sugars that are multi-O-methylated. PGL is thought to contribute to the 
intracellular survival of M. leprae within macrophages of individuals with lepromatous 
leprosy through its ability to scavenge oxygen radicals. The variable oligosaccharide 
constituents of these glycolipid antigens are usually of sufficient antigenicity as to 
evoke corresponding specific antibodies and thereby allow serodiagnosis of individual 
mycobacterioses and leprosy (Gaylord and Brennan, 1987). PGL is apparently not 
found in the sequenced strains of Mtb thought to be due to a frame shift mutation 
between two genes encoding polyketide synthases pks1-15 (Constant et al., 2002). 
Although not produced by the laboratory strains of Mtb, epidemiologically more 
prevalent Beijing strains produce PGL and are shown to be more virulent. PGL was also 
shown to inhibit production of proinflammatory cytokines in bone marrow derived 
mouse macrophages, which were previously stimulated with apolar lipids of an Mtb 
pks1-15 mutant (Reed et al., 2004). 
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Fig 2: Structure of three major classes of extractable glycolipids of the mycobacterial cell wall 
adapted from (Brennan and Nikaido, 1995).  
1.6 Analysis of Mycobacterial Lipids 
The introduction of the new spectroscopic and chromatographic techniques since the 
early 1960s has revolutionised the approaches to the analysis of these relatively 
intractable natural compounds. Thin layer (TLC), gas and high performance liquid 
chromatographic techniques (HPLC) allow the preparation of reproducible lipid profiles 
and the rapid small-scale isolation of individual components. Radio labelling of lipids 
with specific radiolabelled substrates combined with chromatography aids in the 
biochemical characterisation of the lipid. Mycobacterial lipids are radiolabelled by 
growing mycobacteria in a medium containing specific substrates which are radioactive. 
Lipids are radiolabelled when bacteria uses the radioactive substrate to synthesise the 
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lipid. These lipids can be extracted using organic solvents and analysed by 
chromatography.  
Thin Layer Chromatography 
TLC is the most commonly used chromatographic technique to generate lipid profiles. 
It is a simple, quick, and inexpensive procedure that gives a quick answer as to how 
many lipid components are in a mixture. TLC is also used to support the identity of a 
compound in a mixture by comparing the retention factor (RF) value of the sample with 
that of a standard. A TLC plate is a sheet of glass, metal, or plastic which is coated with 
a thin layer of a solid adsorbent (usually silica or alumina). A small amount of the 
mixture to be analysed is spotted near the bottom of this plate. The TLC plate is then 
placed in a shallow pool of a solvent in a developing chamber so that only the very 
bottom of the plate is in the liquid. This liquid, or the eluent, is the mobile phase, and it 
slowly rises up the TLC plate by capillary action. As the solvent moves past the spot 
that was applied, equilibrium is established for each component of the mixture between 
the molecules of that component which are adsorbed on the solid and the molecules 
which are in solution. In principle, the components will differ in solubility and in the 
strength of their adsorption to the adsorbent and some components will be carried 
farther up the plate than others. When the solvent has reached the top of the plate, the 
plate is removed from the developing chamber, dried, and the separated components of 
the mixture are visualised. Visualisation is done using reagents that react with the lipid 
or the sugars of glycolipids etc to give colours to the spots. When the samples are 
coloured, spots can be seen with naked eye. Alternatively plates can be viewed under 
UV-light. In the case that lipids are radiolabelled X-ray films can be placed over the 
plate and later developed to reveal the spots.  
Mass spectrometry and Nuclear magnetic resonance spectroscopy facilitate the precise 
determination of the masses and functional groups of the lipid to be analysed. Most of 
the mycobacterial lipids have been structurally characterized employing these two 
techniques. 
Mass Spectrometry 
Mass spectrometry is unlike most other forms of spectroscopy or spectrometry that are 
concerned with non-destructive interactions between molecules and electromagnetic 
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radiation. A mass spectrometer converts sample molecules into ions in the gas phase, 
separates them according to their mass to charge ratio (m/z) and sequentially records the 
individual ion current intensities at each mass - the mass spectrum. The principle of the 
mass spectrometer is simple though details vary enormously. Atoms from the material 
to be studied are ionized, accelerated to a known energy by passing through a potential 
difference, and then passed through a magnetic field which separates particles with 
different momentary. The ions can be produced by bombarding atoms in the residual 
gas with an electron beam in the ion source. The (positively charged) ions are then 
accelerated by the voltage which can be adjusted to choose ions of the desired mass. 
Some of the ions pass through a slit and enter a region with a uniform magnetic field. If 
voltage is chosen correctly, ions of the appropriate mass are deflected by the magnetic 
field, pass through a second slit, and are detected in an ion collector. The amplified 
signal from the ion collector is a measure of the ion current. These ion current 
intensities are drawn in histogram form taking the most intense ion current as 100%, the 
values of m/z versus percentage relative intensity. The mass peaks can be compared 
with standards to identify compounds or with the theoretical mass of a compound. 
Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance, or NMR, is a phenomenon which occurs when the nuclei 
of certain atoms are immersed in a static magnetic field and exposed to a second 
oscillating magnetic field. Some nuclei experience this phenomenon, and others do not, 
dependent upon whether they possess a property called spin. All nuclei that contain odd 
numbers of protons or neutrons have an intrinsic magnetic moment and angular 
momentum. The most commonly measured nuclei are hydrogen-1 (the most receptive 
isotope at natural abundance) and carbon-13, although nuclei from isotopes of many 
other elements can also be observed. NMR studies magnetic nuclei by aligning them 
with a very powerful external magnetic field and perturbing this alignment using an 
electromagnetic field. The resulting response to the external perturbing electromagnetic 
magnetic is the phenomenon that is exploited in nuclear magnetic resonance 
spectroscopy. 
1.7 Mycobacterium marinum as a Model  
Although some genetic tools for studying Mtb are now available, it remains a difficult 
organism to work with. This has turned many investigators towards related organisms. 
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M. marinum has become increasingly useful as a model organism. It causes fatal 
infection in fresh and salt water fish as well as amphibians. In humans it is the causative 
agent of a disease called swimming pool granuloma (Wolinsky, 1992); (Collins et al., 
1985). A recent case study expands the spectrum of infection caused by M. marinum to 
granulomatous pulmonary disease in humans (Lai et al., 2005).  Signature mechanisms 
of tuberculosis disease initiation, namely retardation of PM and granuloma formation 
are conserved between M. marinum and M. tuberculosis (Barker et al., 1997). Faster 
growth of M. marinum compared to that of M. tuberculosis and its phylogenetic 
closeness to M. tuberculosis complex have been exploited to some extent. Utilising 
M. marinum as a model, granuloma-specific expression of virulence proteins from the 
glycine rich PE-PGRS family (Ramakrishnan et al., 2000) and MmW04 gene involved 
in intracellular survival and pigmentation have been identified (Gao et al., 2003a). 
Studies using M. marinum mutants helped to identify kasB as a novel drug target in 
mycobacteria. This gene is required for full elongation of mycolates. The respective 
mutants have increased permeability of their cell walls with the consequence of 
impaired growth within macrophages (Gao et al., 2003b) and loss of acid fastness in 
Mtb (Bhatt et al., 2007). A M. marinum virulence factor as yet not found in other 
virulent mycobacteria is the escape from their phagosome to the cytosol and a capability 
for cell to cell spreading by polymerising actin of the host cell (Stamm et al., 2003). 
The archetypical mycobacterial pathological feature of granuloma formation in tissues 
has been addressed in an elegant study using M. marinum. It was shown that existing 
granulomas fail to eliminate invading naïve mycobacteria that traffic to them (Cosma et 
al., 2004). More recently additional roles for ESAT-6 (Early secreted antigen) and CFP-
10 (Culture filtrate protein) in impeding PM and the essentiality of Erp (exported 
repetitive protein) in mounting an initial infection have been established using M. 
marinum (Cosma et al., 2006); (Tan et al., 2006). The diversity of possible approaches 
used in these studies validates the utilization of M. marinum as a model to study 
mycobacterial pathogenesis. It was one of the aims of this work to apply a genetic 
screen to M. marinum and ask whether the genes involved in the important 
mycobacterial virulence trait, namely inhibition of PM, can be identified and further 
studied. 
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 2  Objectives 
The objective of this study was to identify and characterise mycobacterial virulence 
factors that are involved in the inhibition of PM.  
The availability of mycobacterial genomes have facilitated several genetic screens, 
designed to identify genes implicated in the infection process. Although it is likely that 
the resulting list of genes from such screens contain mediating factors arresting PM, the 
lists are too complex to identify such components directly. Moreover, the lysosomal 
milieu is clearly bacteriostatic and only weakly bacteicidal for Mtb. Therefore, using 
bacterial death to identify mutants defective in arresting PM will be misleading and will 
be masked by other deleterious mutations. Hence, the primary objective was to design a 
screening technique to sift through a pool of mycobacterial mutants for mutants 
particularly defective in inhibiting PM. This objective was to be addressed using 
M. marinum as a model for other virulent mycobacteria, namely Mtb. 
As with any other screening techniques validity of the screen can be assessed only by 
demonstrating atleast some of the mutants have the predicted phenotype. In order to 
study the phenotype of the mutants the maturation status of the phagosomes containing 
mutants has to be analysed. Therefore one of the aims of this thesis was also to develop 
necessary tools to study phagosome maturation.   
Finally, the resulting lists of genes from genetic screens are less informative unless the 
effector molecules the genes directly or indirectly codes for is known. Therefore, 
investigations were carried out to pin down the effector molecules encoded by the 
affected genes of the mutants that directly inhibit PM.  
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 3  Materials and Methods 
3.1 Materials 
3.1.1 Instruments Used 
Name of the Instrument Brand Name Manufacturer 
β-Scintillation counter 1217 Rackbeta  LKB Wallac 
Agarose gel electrophoresis 
apparatus 
Mini-sub Cell GT Bio-Rad 
Capillary electrophoresis 
sequencer 
ABI PrismTM 310 Genetic 
Analyzer 
Applied Biosystems 
Cell mill MM2000 Retsch 
Centrifuge Table top: Sepatech 15Biofuge Heraeus 
CO2 Incubator Hera cell 240 Heraeus 
Electroporator E. coli pulser Biorad 
Flowcytometer FACScanTM Becton Dickinson 
Fluorescence microscope IX81 Olympus 
Gel documentation apparatus Geldoc 2000 Bio-Rad 
Heating Plate (TLC) Thermoplate S Desaga/Sarstadt 
Hybridization oven OV1 Biometra 
Laminar air flow bench Herasafe KSP15 Heraeus 
Mass spectrometer Q-TOF 2 Micromass 
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NMR spectrometer AMX 500 Bruker 
pH meter Multical WTW 
Shaker incubator InnovaTM 4200 New Brunswick  Scientific 
Sodium dodecyl sulphate - 
Polyacrylamide agarose gel 
electrophoresis (SDS-PAGE) 
apparatus  
Mini Protean II Bio-Rad 
Sonicator bath Sonorex TK30 Bandelin 
Spectrophotometer SmartSpecTM Plus Bio-Rad 
Thermal block Thermomixer Comfort Eppendorf 
Thermal Cycler PTC200 MJ Research 
Tissue culture microscope CKX41 Olympus 
UV-Cross Linker UVC500 UV cross linker Hoefer 
Vacuum blot apparatus 
(Southern Blot) 
Vacuum Blotter Apligene 
Vortexer Reax2000 Heidolph 
Water Bath Type: 1002 Geselschaft für Labortechnik  
Weighing  Balance Genius Sartorius 
Western Blot apparatus  Mini Trans Blot Bio-Rad 
X-ray film developer  Agfa Curix 60 Agfa 
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3.1.2 Chemicals, Media and other Accessories Used 
Chemicals and accessories Manufacturer 
β-galactosidase assay kit Boehringer Mannheim, Germany 
14C palmitate supplemented Middlebrook 7H12 
medium 
BACTEC, Becton Dickinson, MD, USA  
Acetic acid Merck KGaA, Darmstadt, Germany 
Agarose Seakem ME, Lonza GmbH, Wupertal, Germany 
Alexa568 dextran Molecular Probes, Invitrogen GmbH, Karlsruhe, 
Germany 
Alexa568 transferrin  Molecular Probes, Invitrogen GmbH, Karlslruhe, 
Germany 
Alexa594 anti mouse IgG Molecular Probes, Invitrogen GmbH, Karlsruhe, 
Germany 
Ampicillin Sigma-Aldrich Chemie, Steinheim, Germany 
Carboxyl- 14C p-hydroxy benzoic acid American Radiochemicals, Cologne, Germany 
Cationic lipid transfection reagent 
(Lipofectamine) 
Invitrogen GmbH, Karlsruhe, Germany 
CDP star detection kit GE Healthcare Europe GmbH, Munich, Germany 
Cell scrapper Greiner bio-one, Frickenhausen, Germany 
Chloroform Merck, Darmstadt, Germany 
Copper sulphate Roth, Karlsruhe, Germany 
Cover slip Engelbrecht, Edermünde, Germany 
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Cytochalasin B Sigma-Aldrich Chemie, Steinheim, Germany 
Di chloromethane Merck KGaA, Darmstadt, Germany 
DIG DNA labelling kit Roche Applied Science, Mannheim, Germany 
DMEM (Dulbecos minimum essential medium) Gibco, Invitrogen GmbH, Karlsruhe, Germany 
DTT (dithiothreitol) Sigma-Aldrich Chemie, Steinheim, Germany 
EDTA (ethylene diamine tetraacetic acid)  Roth, Karlsruhe, Germany 
EGTA (ethylene glycol tetraacetic acid)  Roth, Karlsruhe, Germany 
Enhanced chemiluminescence (ECL)  Kit GE Healthcare Europe GmbH, Munich, Germany 
Entellan Merck KGaA, Darmstadt, Germany 
Eppendorf tubes Sarstedt, Nümbrecht, Germany 
Ethanol Roth, Karlsruhe, Germany 
FITC (fluorescein isothiocyanate) Sigma-Aldrich Chemie, Steinheim, Germany 
Foetal bovine serum (FBS) Sigma-Aldrich Chemie, Steinheim, Germany 
Gateway cloning system Invitrogen GmbH, Karlsruhe, Germany 
Gelatine Merck KGaA, Darmstadt, Germany 
Glass slide Engelbrecht, Edermünde, Germany 
High fidelity DNA polymerase from 
Thermococcus kodakaraensis (KOD DNA 
polymerase) 
Novagen, Merck KGaA, Darmstadt, Germany 
High performance thin layer chromatography Merck KGaA, Darmstadt, Germany 
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(HPTLC) Plate, Silica gel 60 20x10cm 
Histopaque (ficoll for isolating peripheral blood 
monocytes) 
Sigma-Aldrich Chemie, Steinheim, Germany 
Hydrochloric acid Merck KGaA, Darmstadt, Germany 
Hygromycin Boehringer Mannheim 
Hyper film GE Healthcare Europe GmbH, Munich, Germany 
Imidazole Merck KGaA, Darmstadt, Germany 
Infusion cloning Kit Clontech, CA, USA 
Iodomethane Merck KGaA, Darmstadt, Germany 
Kanamycin Sigma-Aldrich Chemie, Steinheim, Germany 
Klenow polymerase New England Biolabs GmbH, Frankfurt, Germany 
Lysozyme Sigma-Aldrich Chemie, Steinheim, Germany  
MACS (Magnetic cell sorting) columns  Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Magnesium chloride Sigma-Aldrich Chemie, Steinheim, Germany 
Magnet Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Dynal, Biotech ASA, Oslo, Norway 
Magnetic agarose beads Qiagen, Hilden, Germany 
Maleic acid Merck, Darmstadt, Germany 
Mannitol Sigma-Aldrich Chemie, Steinheim, Germany 
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Methanol Roth, Karlsruhe, Germany 
Middlebrook 7H10 agar Becton Dickinson, MD, USA 
Middlebrook 7H9 broth Becton Dickinson, MD, USA 
Miltenyi basic beads (iron dextran micro beads) Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany 
Molybdate phosphoric acid Roth, Karlsruhe, Germany 
Mouse anti-EEA-1 BD Biosciences, Heidelberg, Germany 
Mouse anti-LAMP1 BD Biosciences, Heidelberg, Germany 
Mouse anti-LAMP2 Southern Biotech, Alabama, USA 
Mouse anti-Rab5 BD Biosciences, Heidelberg, Germany 
Mouse-anti-β galactosidase Abnova, Taipei City, Taiwan  
Multi-well tissue culture plates Nunc, IL, USA 
My one beads (hydrophillic beads) Dynal Biotech ASA, Oslo, Norway 
Ni-NTA (Nickel-nitrilotriacetic acid) Qiagen, Hilden, Germany 
N-lauryl sarcosine Serva, Heidelberg, Germany 
Oleic acid albumin dextrose complex (OADC) Becton Dickinson, MD, USA 
Opti-MEM 1 medium Invitrogen GmbH, Karlsruhe, Germany 
Parafilm Pechiney Plastic Packaging, IL, USA 
Paraformaldehyde Sigma-Aldrich Chemie, Steinheim, Germany 
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PBS (phosphate buffer saline) Biochrom, Berlin, Germany 
PCR purification kit Qiagen, Hilden, Germany 
Perchloric acid Merck, Darmstadt, Germany 
Petriperm Greiner Bio-one, Frickenhausen, Germany 
Petroleum ether Merck KGaA, Darmstadt, Germany 
PIPES (piperazine-N,N’- bis ethansulfonic acid) Sigma-Aldrich Chemie, Steinheim, Germany 
Plasmid mini-prep kit Qiagen, Hilden, Germany 
PMSF (phenylmethylsulphonyl fluoride) Sigma-Aldrich Chemie, Steinheim, Germany 
Polystyrene fluorescent beads Bangs Laboratories inc, IN, USA 
Potassium chloride (KCl) Merck KGaA, Darmstadt, Germany 
Potassium hydroxide (KOH)  Merck KGaA, Darmstadt, Germany 
Primers MWG Biotech, Martinsried, Germany 
Prolong anti-fade gold Molecular Probes, Invitrogen GmbH, Karlsruhe, 
Germany 
Protease inhibitor Roche Applied Science, Mannheim, Germany 
Protein estimation kit Perbio Science GmbH, Bonn, Germany 
PVDF membrane GE Healthcare Europe GmbH, Munich, Germany 
Rabbit anti-EGFP Molecular Probes, Invitrogen GmbH, Karlslruhe, 
Germany 
Restriction endonucleases New England Biolabs, Frankfurt, Germany 
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RPC-18 beads (hydrophobic beads) Dynal Biotech ASA, Oslo, Norway 
RPMI-1640 medium (Roswell Park Memorial 
Institute medium) 
Biochrom, Berlin, Germany 
Saponin Sigma-Aldrich Chemie, Steinheim, Germany 
Scintillation fluid Zinsser Analytic, Berkshire, UK 
Serum Free medium for macrophages Gibco, Invitrogen, USA 
Sodium bi carbonate Merck KGaA, Darmstadt, Germany 
Sodium chloride (NaCl) Merck KGaA, Darmstadt, Germany 
Sodium dodecyl sulphate (SDS) Serva, Heidelberg, Germany 
Sodium hydroxide (NaOH) Merck KGaA, Darmstadt, Germany 
Sucrose Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
Sulphuric acid (H2SO4) Merck KGaA, Darmstadt, Germany 
Syringe Omnifix, B Braun, Melsungen, Germany 
Syringe needle BD Microlance, Becton Dickinson 
Taq polymerase Qiagen, Hilden, Germany 
Tetra-n-butyl ammonium hydrogen sulphate Merck KGaA, Darmstadt, Germany 
Thinlayer chromatography (TLC) plate silica gel 
60 20x20cm 
Merck KGaA Darmstadt, Germany 
Tissue culture flasks Nunc, IL, USA 
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Toluene Roth, Karlsruhe, Germany 
Triethanolamine Sigma-Aldrich Chemie, Steinheim, Germany 
Tris Roth, Karlsruhe, Germany 
TRITC (tetramethylrhodamine-5-isothiocyanate) Sigma-Aldrich Chemie, Steinheim, Germany 
Tween 20 Sigma-Aldrich Chemie, Steinheim, Germany 
Whatmann3 Paper  Schleicher and Schüll, Germany 
X-ray film Fujifilm, Düsseldorf, Germany 
X-ray film cassette Siemens, Germany 
Zwittergent 3-12 Calbiochem, Merck KGaA Darmstadt, Germany 
 
3.1.3 Oligonucleotides 
Name Sequence Use 
ARB1 5’-GGCCACGCGTCGACTAGTAC 
NNNNNNNNNN-‘3 
Sequencing of Mutants 
ARB2 5’-GGCCACGCGTCGACTAGTAC -3’ Sequencing of Mutants 
P1_1064F1 5’-TGCGGCCGCTCTAGATGCGG 
TCAGGTATGTCAGCA–3’ 
Trans complementation of mutant P1 
P1_8007R2 5’-GGGGGATCCACTAGTCTATC 
GACGCTGGCGCAT–3’ 
Trans complementation of mutant P1 
P1N_del_F1 5’-TGCGGCCGCTCTAGACGATG 
AGTTGTGGGCGAA-3’ 
Construction of Nested deletion 
plasmids 
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P1N_del_F2 5’-TGCGGCCGCTCTAGAATGCG 
ACATCAGTTCGGG–3’ 
Construction of Nested deletion 
plasmids 
P1N_del_F3 5’-TGCGGCCGCTCTAGAATGAT 
AGAATCTCACTAC–3’ 
Construction of Nested deletion 
plasmids 
P1N_del_R1 5’-GGGGGATCCACTAGTGTGAG 
CGGCGGCGTCCCG–3’ 
Construction of Nested deletion 
plasmids 
P1N_del_R2 5’-GGGGGATCCACTAGTGTGGA 
GTCGCATCGGCGC–3’ 
Construction of Nested deletion 
plasmids 
P1N_pQE10_BD_F2 5’-TCACCATACGGATCCGATAG 
AATCTCACTAC - 3’ 
Cloning pmiA into an expression vector 
P1N_pQE10_BD_R1 5’-CAGCTAATTAAGCTTTTAAT 
TACGTCGGGCGCC-3’ 
Cloning pmiA into an expression vector 
P1N_pQE18_BD_F1 5’-ACTATGAGAGGATCCATGAT 
AGAATCTCACTAC-3’ 
Cloning pmiA into an expression vector 
P1N_pQE18_BD_R2 5’-GAGATCGGAAGATCTCAGGG 
GTATAGGTGTAAT-3’ 
Cloning pmiA into an expression vector 
Rab_BD-
infusion_fwd1 
5’-TCTTGTCGACCTCGAGCAGG 
TCGTTACATAACT-3’ 
Cloning of Rab5- and Rab7-EGFP 
fusion proteins into pENTRY vector 
Rab_BD-
infusion_rev1 
5’-TAGCGAGCTCTCTAGCCAGA 
CATGATAAGATAC-3’ 
Cloning of Rab5- and Rab7-EGFP 
fusion proteins into pENTRY vector 
RPCRa1 5’-CTTGCTCTTCCGCTTCTTCT C-3’ Sequencing of Mutants 
RPCRa2 5’-CTCTACACCGTCAAGTGCGAAGAG-
3’ 
Sequencing of Mutants 
RPCRb1 5’-CAGGCACGTCGAGGTCTTTC -3’ Sequencing of Mutants 
RPCRb2 5’-CTTTCAGATGGATGGCGTAG -3’ Sequencing of Mutants 
   
47
3.1.4 Plasmids 
Name Marker Description Source 
pGPC330 
(pEGFP-Rab11b) 
Kanar Plasmid containing Rab-11b GFP fusion 
protein construct 
(Rzomp et al., 2003) 
pGPC15 (pOLYG) Hygr E.coli – Mycobacteria shuttle vector with a 
Hygromycin resistance cassette 
(Ó Gaora et al., 1997) 
pGPC331 
(pENTRY) 
Kanar  Invitrogen 
pGPC335 (pGreen 
Lantern-Rab5a) 
Ampr Plasmid containing Rab-5a GFP fusion 
protein construct 
Generously provided by 
Craig Roy, Yale 
University, New Haven, 
Connecticut 
pGPC336 (pGreen 
Lantern-Rab7) 
Ampr Plasmid containing Rab-7 GFP fusion 
protein construct 
Generously provided by 
Craig Roy. 
pGPC352 Hygr pmiA spanning region cloned into pOLYG 
used for trans-complementation 
From this work 
pGPC358 Ampr Rab11b-GFP containing adenoviral vector From this work 
pGPC359 Ampr Rab5a-GFP containing adenoviral vector From this work 
pGPC360 Ampr Rab7 containing adenoviral vector From this work 
pGPC363 Ampr pmiA cloned into pQE10 (n-terminal his-
tag) 
From this work 
pGPC364 Ampr pmiA cloned into pQE18 (c-terminal his-
tag) 
From this work 
pGPC369 Hygr PCR Nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
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pGPC370 Hygr PCR nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
pGPC371 Hygr PCR Nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
pGPC372 Hygr PCR Nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
pGPC373 Hygr PCR Nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
pGPC374 Hygr PCR Nested deletion fragments of pmiA 
spanning region cloned into pOLYG 
From this work 
pGPC81 Ampr Adenoviral vector Kindly provided by 
Andreas Untergasser 
pQE10 Ampr His tag expression vector Qiagen 
pQE16 Ampr DHFRS (dihydrofolate reductase)-His-tag 
; expression vector 
Qiagen 
pQE18 Ampr His-tag  expression vector Qiagen 
pUC4K kanar Vector with kanamycin resistance 
cassette 
Pharmacia 
 
3.1.5 Bacterial Strains 
Strain Characteristics Source 
E. coli DH5α F-(φ80dΔlacZM15) Δ (lacZYA-argF)U169 
deoR 
Invitrogen GmbH, Karlsruhe, 
Germany 
E. coli NM554 MC1061 recA13 NEB, Frankfurt, Germany 
   
49
M. marinum 
(ATCC 927) 
Mycobacterium marinum strain isolated from 
fish 
Dept Microbiologie, Instituut voor 
Tropische Genes Kunde, 
Antwerpen, Belgium 
M. marinum 
mutants 
Transposon mutant library generated in M. 
marinum (ATCC927) 
(Rybniker et al., 2003) 
 
3.1.6 Cell Lines 
Cell Line Characteristics Source 
HEK 293 Human embryonic kidney cell line  (Graham et al., 1977) 
 
3.2 Methods 
3.2.1 Culturing Human Monocyte Derived Macrophages (HMDM) 
Buffy coats were obtained from the University clinic blood bank, University of Cologne. 
The buffy coat obtained from a 500ml blood donation of the same day was split into two 
50ml tubes. It was further diluted 1:1 with RPMI medium. The diluted buffy coat was 
layered on a 15ml histopaque gradient. The discontinuous gradient was centrifuged at 
1600rpm for 40 minutes and the centrifuge was brought to halt without applying brakes. 
Monocytes layered in the interface were carefully transferred out into a fresh 50ml tube. 
The isolated monocytes were then washed with RPMI twice by centrifuging at 900rpm for 
10 minutes. The monocytes were counted using a Neubauer chamber and adjusted to a 
density of 3x106cells/ml with tissue culture (TC) medium [RPMI containing 5% foetal 
bovine serum (FBS)]. These cells were plated on serum opsonised TC flasks, dishes or 
petriperms as required. The monocytes were allowed to adhere on to the base overnight at 
37oC in a 5% CO2 atmosphere. After an overnight incubation the cells were washed with 
pre-warmed RPMI medium to remove the non-adherent cells. The adherent cells were 
allowed to differentiate into macrophages for another 6 days. Cells were renewed with TC 
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medium (RPMI containing 5% FBS) every second day. The differentiated macrophages 
were used for further experiments. 
3.2.2 Screening for Mutants Incompetent in Retarding Phagosome Maturation 
3.2.2.1 Preparation of Single Cell Suspension of Mycobacteria for Infection 
More than 4000 colonies of transposon mutants grown on a 7H10 agar plate were scraped 
off using a cell scraper and suspended in 7H9 broth in a 15ml tube. Bacteria were washed 
with phosphate buffer saline (PBS) three times by centrifuging at 5000rpm. The bacterial 
pellet was then resuspended in 1ml of RPMI. A small amount of glass beads of 0.2mm 
diameter were added and shaken on a mill for 5min to disrupt the clumps. Glass beads and 
the bacterial clumps were removed by centrifuging at a low speed of 600rpm for 5min. 
After centrifugation the supernatant was collected without disturbing the pellet. The 
collected supernatant was then passed through a 27 gauge needle three times. The 
bacterial suspension was then centrifuged at 600rpm for 5min to make sure that there were 
no bacterial clumps left. Optical density (OD) was measured on a spectrophotometer at 
600nm. The OD values were used as a measure for the number of bacterial cells. This 
bacterial suspension was used to infect HMDM.  
3.2.2.2 Endocytosis of Iron Dextran Beads 
3x106 HMDM were seeded on 10 petriperms (Tissue culture dish with a hydrophilic 
membranous base) and pulsed with 0.5ml of 1:10 diluted colloidal iron dextran particles 
(Miltenyi basic beads) suspended in TC medium (RPMI). Micro beads (Miltenyi basic 
beads) were pulsed for one hour at 37oC in a CO2 incubator. After one hour HMDM were 
washed with RPMI repeatedly (three times) to remove the non-endocytosed beads. The 
endocytosed beads were further chased for another 2hrs. After the chase HMDM 
monolayers were rinsed with RPMI once and used for infection. 
3.2.2.3 Infection of Iron Dextran Pre-fed HMDM with M. marinum Transposon 
Mutants 
HMDM that were pre-fed (3.2.2.2) with microbeads infected with 3x107 transposon 
mutants prepared as described in section 3.2.2.1. HMDM were pulsed with bacterial 
suspension in TC medium (RPMI) for 2hrs at 37oC. After 2hrs the macrophage culture 
was washed with RPMI to remove the non-phagocytosed bacteria. Three repeated 
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washings were done. HMDM were replenished with RPMI containing 5% FBS. The 
phagocytosed bacteria were then chased overnight at 37oC in a 5% CO2 atmosphere.  
3.2.2.4 Isolation of Phagolysosomes Containing M. marinum Mutants and 
Phagolysosomal Marker 
Buffers Used 
Equilibration Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 1mM DTT and 
 10μM Cytochalasin B. 
Lysis Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 220mM Mannitol; 
 68mM Sucrose. 
Wash Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 1mM DTT. 
After an overnight chase HMDM were rinsed twice with PBS. 750µl of equilibration 
buffer was added to the cells followed by incubation on ice for 20min. After the 
incubation 250µl lysis buffer was added and HMDM were scrapped off using a rubber 
policeman and collected in a 2ml tube (eppendorf). The collected cell suspension was 
passed through a 23 gauge needle at least 15 times. 100µl of the homogenized cell 
suspension was kept aside for β-galactosidase assay. The remaining fraction was applied 
on a mini-MACS column mounted on a magnet. The MACS column was pre-equilibrated 
with wash buffer before applying the sample. A fraction of the flow-through was saved 
for β-galactosidase assay. The column was washed three times with wash buffer. The 
washings were collected and saved. The column was next removed from the magnet to 
release the bound organelles and 1ml of 7H9 medium was flushed through using a piston. 
The flow-through containing the mutant phagosomes was collected and a sample was kept 
aside for β-galactosidase assay and the remaining centrifuged at 15,000rpm for 2min. The 
pellet was resuspended in 200µl of 7H9 broth and 100µl of the suspension was plated on 
to two 7H10 agar plates. The inoculated agar plates were then incubated at 30oC for 5 
days until the colonies became just visible. Colonies were scraped off and treated as 
described to obtain a single cell suspension (3.2.2.1) and used for HMDM infection. The 
screen was repeated a total of three times. From the third screen 100 individual clones 
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were picked and inoculated individually on 7H10 agar plates. Subcultures of these clones 
were again inoculated on 7H10 agar plates and used to prepare frozen stocks at -80oC. 
3.2.3 Southern Blot Analysis 
3.2.3.1 Extraction of Mycobacterial Chromosomal DNA  
Buffers 
Lysis Buffer 
25% Sucrose; 50mM Tris pH 8.0; 1mM EDTA. 
TE Buffer 
10 mM Tris-HCl pH 7.5; 1 mM EDTA.  
A loop of mycobacteria grown on 7H10 agar plate was taken and suspended in 400µl lysis 
buffer in an eppendorf tube and vortexed well. A small amount of glass beads was added 
to the bacterial suspension which was then agitated in a cell mill (Retsch MM2000) for 
2min at maximum amplitude. The tubes were removed from the mill 10µl lysozyme 
(40mg/ml) was added to each followed by incubation on ice for 5min. After the 
incubation 4µl ProteinaseK (10mg/ml), 40µl 0.5M EDTA and 16µl sarcosyl (35%) were 
added and incubated on ice for further 1hr, followed by an overnight incubation at 50°C. 
Next morning the cell debris was removed by spinning at 15,000rpm for 5min discarding 
the pellet. The supernatant was collected in a separate tube and 0.5 volume of 7.5M 
ammonium acetate was added before centrifugation at 15,000rpm for 30min to precipitate 
DNA. The DNA pellet was washed with 500µl 70% ethanol by centrifuging at 15,000rpm 
for another 30min. The pellet was dried and resuspended in 50µl TE buffer. OD was 
measured to quantify the DNA obtained. 
3.2.3.2 Restriction Enzyme Digestion and Blotting 
Buffers 
Denaturation Buffer 
1.5M NaCl and 0.5M NaOH 
Neutralization Buffer 
0.5M Tris/HCl pH 7.0 and 3M NaCl 
20X SSC Buffer  
3M NaCl; 0.3M sodium citrate and pH adjusted to 7 
   
53
Hybridization Buffer 
Formamide 50%; 5X SSC; 2% Blocking reagent; 0.1% N-Lauryl sarcosine; 0.02% 
 SDS. 
4μg of extracted chromosomal DNA of wild-type (WT) M. marinum or mutants isolated 
and was digested with BamHI endonuclease. The restricted DNA was separated by 
electrophoresis on an agarose gel. The DNA in the gel was fragmented by submerging the 
gel in 0.25M HCl for 10min followed by a brief washing with distilled water. After 
fragmentation DNA was denatured by incubating the gel in denaturation buffer for 15min 
at RT. After 15min the solution was changed and a fresh solution of denaturation buffer 
was added and incubation continued for another 30min at RT followed by a washing with 
distilled water. After denaturation the gel was neutralised by placing it in neutralisation 
buffer at RT for 15min. The incubation was repeated with a fresh change of neutralisation 
buffer. 
Whatman3 paper and nylon membrane (NytranN) were cut to the size of the gel and 
equilibrated by dipping in 2X SSC buffer and placed on a vacuum blot apparatus. The gel 
was placed over the membrane and 55-60mbar vacuum was applied to initiate transfer for 
60min. The gel was not allowed to dry by adding 20X SSC buffer on top of the gel. After 
the transfer the membrane was removed, washed once with 2X SSC buffer and the DNA 
was crosslinked in a UV cross linker apparatus (UVC500 UV cross linker) before pre-
hybridization by incubating the membrane in hybridization buffer for 4hrs at 42°C.  
3.2.3.3 Digoxigenin (DIG) Labelling and Hybridization 
A probe specific for the aph gene was prepared by restricting the aph gene from PUC4K 
plasmid with pstI. Restriction fragments were separated by electrophoresis on a 0.7% 
agarose gel. A band of approximately 1.5kb size corresponding to the aph gene was sliced 
out of the gel. DNA was extracted from the gel slice and purified using Qiagen gel 
extraction kit following the manufacturer’s protocol. The extracted DNA was denatured 
by boiling for 10min and immediately cooled down to -20°C. Hexanucleotide mix, dNTP 
labelling mix and klenow polymerase were added to the DNA and incubated at 37°C 
overnight. The reaction was stopped by adding 2µl of 0.2M EDTA. The DIG labelled 
DNA was further purified using Qiagen PCR purification kit.  Following the addition of 
the probe, hybridization to the filter cross-linked DNA was done in hybridization buffer 
for a brief period at 80°C and overnight at 42°C. Thereafter the hybridization membrane 
   
54
was washed with 2X SSC buffer containing 0.1%SDS twice at RT (5min each wash), 
followed by washing with 0.2X SSC buffer containing 0.1%SDS twice at 68°C (15min 
each wash). Finally the membrane was developed using CDP star luminescence detection 
reagent. 
3.2.3.4 Enhanced Chemiluminescence (ECL) Detection 
Buffers 
Buffer 1 
Maleic acid 0.1 M, NaCl 0.15 M in water and pH adjusted to 7.5 with 1N NaOH. 
Wash Buffer  
Buffer 1 + 0.3% Tween 20 
Buffer 2 
Blocking buffer diluted 1:10 in buffer1  
Buffer 3 
Tris/HCl 0.1M; NaCl 0.1M, MgCl2 50 mM in water and pH adjusted to 9.5 
The hybridized membrane was washed with wash buffer and then incubated in buffer2 for 
30min. Anti-DIG-alkaline phosphatase conjugated antibody was diluted 1:10000 in 
buffer2 and the membrane was incubated in this solution for 30min. After the incubation 
the membrane was washed with wash buffer twice (15minutes each). Washing was 
followed by equilibration in buffer3 for 5min. The blot was transferred on to a polythene 
sheet and the ready to use CDP star substrate solution was added and incubated at 37°C 
briefly. The excess substrate solution was removed and washed gently with buffer3. The 
polythene sheet was sealed and exposed on to X-ray film in the dark for different time 
periods.  
3.2.4 Cloning by Homologous Recombination using “Infusion Kit” 
Buffers 
TE Buffer 
10 mM Tris-HCl pH 7.5; 1 mM EDTA.  
3.2.4.1 Cloning 
Plasmid was restricted with suitable restriction enzymes and mixed with fragments of 
PCR amplified using a high fidelity polymerase from Thermococcus kodakaraensis (KOD 
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DNA Polymerase) in a 2:1 vector/insert molar ratio according to the recommendations of 
the manufacturer (Clontech). The final volume was made up to 10µl. The 10µl mixture 
was added to an “Infusion” reaction tube. The reaction mix was incubated at 42oC for 
30min and then immediately stopped on ice. The reaction mix was diluted by adding 40µl 
of TE buffer.  
3.2.4.2 Transformation 
3µl of the diluted reaction mix was transformed into “Infusion blue” (Clontech) competent 
cells. The transformation was done by heat shocking the cells at 42oC in a water bath for 
45sec followed by incubation on ice for one minute. Then 450µl of SOC medium was 
added to the tube and it was incubated at 37oC for 1hr. After 1hr 100µl of the cells were 
plated on a LB agar plate containing 50µg/ml ampicillin. The plates were incubated at 
37oC overnight. Next day the colonies grown on the plate were picked and inoculated into 
LB broth containing 50µg/ml ampicillin for plasmid DNA preparation.  
3.2.4.3 Plasmid Preparation  
Bacterial culture was centrifuged to obtain the bacterial pellet and the plasmid was 
isolated using Qiagen mini prep kit as per the manufacturer’s protocol. The plasmids were 
checked for the inserted gene fragment by restricting them with appropriate restriction 
enzymes and electrophoresing on 0.7% agarose gel with appropriate size standards. 
3.2.5 Western Blot Analysis 
Buffer 
Transfer Buffer 
Methanol 400ml; Glycine 28.8g; Tris 6.6g 
Blocking Buffer 
PBS containing 0.5% Gelatin and 0.1% Tween20 
Protein samples were separated on a SDS-PAGE. Hybond-PVDF membrane was pre-
wetted in 100% methanol for 5sec followed by water for 5min and then equilibrated in 
transfer buffer for 10min. Membrane was not allowed to dry. The SDS gel was also 
equilibrated in transfer buffer for 10min. A fibre pad was wetted in transfer buffer and 
placed on the transfer chamber.  Over the pad two Whatman3 paper sheets of the size of 
the gel dipped in transfer buffer was placed. The gel was placed upon the stack and the 
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membrane over the gel. The membrane and gel were sandwiched with another 2 sheets of 
whatman3 paper wetted with transfer buffer. The transfer chamber was closed and placed 
on ice. Transfer was done at 250mA for 90min. The membrane was then washed with 
PBS, blocked by incubating in blocking buffer overnight on an orbital shaker and then 
was washed three times (5min each wash) with PBS containing 0.1% Tween20 at RT. 
Primary antibody diluted appropriately in PBS containing 0.1% Tween20 was added to 
the membrane and incubated for 60min at RT. Membrane was washed three times (5min 
each wash) with PBS containing 0.1% Tween20 at RT. Following the washing the 
secondary antibody was diluted appropriately in PBS containing 0.1% Tween 20 and 
added to the membrane and incubated for 60min at RT with constant agitation. Membrane 
was washed three times (5min each wash) with PBS containing 0.1% Tween20 at RT. 
Membrane was placed on a polythene sheet and ECL reagents mixed in a 1:1 ratio were 
added on to it and the polythene sheet was sealed at all sides. Membrane was developed 
by placing polythene bag containing the membrane on a cassette and exposed to an X-ray 
film (Hyperfilm) for 5-60min in dark.  
3.2.6 Rab5-, Rab7- and Rab11-GFP Adenoviral Vector Construction  
3.2.6.1 Cloning of Rab-GFP into Adenoviral Vectors 
Mammalian expression plasmids containing N-terminal fusions of human Rab-GTPases 
tagged to green fluorescent protein (p-Greenlantern-Rab5 and –Rab7) constructs were a 
kind gift from Craig Roy (Boyer centre for Molecular Microbiology and Immunology, 
Yale University School of Medicine, New Haven, Connecticut). Fusion constructs 
pEGFP-Rab11b/Rab11a (Rzomp et al., 2003) was generously provided by Marci A. 
Scidmore (Dept of Microbiology and Immunology, Cornell University, Ithaca, New 
York). Rab5- and Rab7-GFP adenoviral constructs were made by homologous 
recombination (In-fusion kit) (3.2.4.1). Rab5- and Rab7-GFP gene constructs were 
amplified from plasmids pGPC335 and pGPC336 using primers Rab_BD-infusion_fwd1 
and Rab_BD-infusion_rev1. High fidelity polymerase with a proof reading activity (KOD 
DNA Polymerase) was used to amplify the fragments by PCR. The amplified Rab5- and 
Rab7-GFP fusion genes were purified using Qiagen PCR purification kit and cloned into 
pENTRY vector (pGPC331) by homologous recombination (In-fusion cloning kit) 
(2.2.4.l). 
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A Rab11-GFP gene fragment was excised from the plasmid received from M. Scidmore 
using restriction enzymes AseI and MluI. The purified fragment and the XbaI and XhoI 
digested pENTRY vector were blunt ended with klenow polymerase before ligation using 
T4 DNA ligase at RT and transformation into E.coli NM554. The cloned Rab-GFP 
fusions in pENTRY vectors were recombined into an adenoviral vector pGPC81 using 
Gateway system and transformed into E.coli DH5α.  
Following were the adenoviral vectors obtained after recombining the individual pENRY 
vectors containing Rab-GFP constructs into pGPC81. 
pGPC358; Rab11b 
pGPC359; Rab5a 
pGPC360; Rab7 
3.2.6.2 Transfection of HEK 293 Cells to Produce Adenoviral Rab-GFP Constructs 
Human embryonic kidney cell line (HEK 293 cell line) generated by transformation 
human embryonic kidney cell cultures with sheared adenovirus 5 DNA was used to 
generate Rab-GFP fusion adenoviral constructs (Graham et al., 1977). 3µg of plasmids 
pGPC358, pGPC359 and pGPC360 were digested with PacI restriction enzyme. 
Restricted plasmids were purified using Qiagen PCR purification kit. Purified linearised 
plasmids were mixed with 500µl of TC medium (Opti-MEM l) and incubated at RT for 5 
min. At the same time 45µl of cationic lipid transfection reagent (LipofectamineTM) was 
suspended in 2.5ml of Opti-MEM l and incubated at RT for 5min. Opti-MEM l containing 
the restricted plasmid and lipofectamine were mixed and incubated at RT for 20min. The 
mixture was carefully added on to a monolayer of 293 cells in a 25cm2 TC flask and the 
cells were incubated overnight at 37oC in a 5% CO2 atmosphere. Following overnight 
incubation the medium was removed and renewed with fresh medium and incubation 
continued for another day at 37oC in a 5% CO2 incubator. The following day the 
monolayer was dispersed and transferred to a 75cm2 TC flask. The cells were incubated 
until the monolayer started disrupting and cells were found floating in the medium. Cells 
were scrapped off using a cell scrapper and the cell suspension was transferred to a 50ml 
centrifuge tube. Cells were frozen and thawed repeatedly for three times to release the 
virus particles. After freezing and thawing, cell debris was removed by centrifugation at 
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4000 rpm for 10min. Virus titre in the supernatant was determined and virus stocks were 
frozen in aliquots at -80oC. 
3.2.7 Transfection of HMDM and Mouse Dendritic Cells with Rab-GFP 
Adenoviral Vectors  
1 x 106 monocytes isolated from buffy coat, dendritic cells isolated from mouse or mouse 
peritoneal macrophages in TC medium (RPMI containing 5% FBS) were seeded on glass 
coverslips placed in 6 well plates. HMDM were used for transfection on the 6th day of 
culture, dendritic cells were transfected on the 4th day and activated mouse peritoneal 
macrophages on the same day of isolation. Cells cultured on glass coverslips were 
transfected with respective Rab-adenovirus particles suspended in RPMI without FBS at 
an MOI of 100:1. Followed by the addition of virus particles, plates containing the cell 
seeded glass coverslips were centrifuged on a plate centrifuge at 2500rpm for 120min. 
After centrifugation the medium was removed and the cells were replenished with RPMI 
containing 5% FBS. Cells along with virus particles were incubated overnight at 37oC in a 
5% CO2 atmosphere. Cells were viewed under a fluorescence microscope (IX81 
Olympus) for detection of GFP-fluorescence. Cells were also analysed by flowcytometry 
(FACS Calibur) to determine the transfection efficiency. The transfected cells were 
further used to study mycobacterial PM. 
3.2.8 Staining using Antibodies and Immunofluorescence Microscopy 
Buffers 
Permeabilisation/Wash Buffer 
5% BSA and 2% saponin or 0.5% poly ethylene glycol in PBS 
Fixation Buffer 
4% Paraformaldehyde in PBS 
HMDM differentiated on glass cover slips were infected with FITC or TRITC labelled 
mycobacteria at an MOI of 1:1 or pulsed with fluorescent beads (approx 10beads/cell) and 
then fixed using fixation buffer for 20min at RT. Fixation buffer was removed and the 
cells were washed with PBS three times. Cells were permeabilised by incubating in 
permeabilisation buffer at RT for 40min. A 10µl drop of antibody diluted in wash buffer 
containing PBS (antibody dilutions were chosen as per manufacturer’s instruction) was 
placed on a strip of parafilm. Glass coverslips containing permeabilised cells were 
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inverted on the drop of antibody placed on parafilm. Cells were incubated with antibody 
at RT for 1hr. Cells were then washed with wash buffer three times. After washing 
secondary antibody conjugated to a fluorophore (Alexa594, Alexa488) was diluted in 
wash buffer and a 10µl drop of the dilution was placed on a strip of parafilm. Again glass 
coverslips containing the cells were placed on the drop and incubated at RT for 1hr 
followed by washing with wash buffer thrice. The cover slips were then mounted on a 
glass slide over a drop of anti-bleach reagent (Entellan or Prolong anti-gold) and left 
overnight at RT. The following day cells were viewed under an Olympus IX80 
immunofluorescence microscope using a 60X oil immersion lens.  
Rab-GFP adenovirus transfected cells were infected with mycobacteria or pulsed with 
beads, fixed with fixation buffer, washed and mounted on glass slides as described above 
before being viewed under the microscope. 
3.2.9 Staining of Mycobacterium with FITC or TRITC 
Buffers 
Sodium bicarbonate Buffer pH 9.0 
8.4g sodium bicarbonate in 1 litre distilled water pH adjusted with 1N NaOH 
5x107 WT or mutant M. marinum cells were suspended in 200µl of 0.1M sodium 
bicarbonate buffer pH 9.0, containing 1mg/ml FITC or 0.1mg/ml TRITC. Bacteria were 
incubated with the fluorescent dye at 30°C for 30 minutes. After incubation the excess dye 
was removed by three repeated washings with PBS. Bacteria were then resuspended in TC 
medium (RPMI) treated as described earlier to make single cell suspension (3.2.2.1) and 
then used for macrophage infections. 
3.2.10 Growth Rate of M. marinum 
6 well plates were seeded with 2x106 monocytes isolated from buffy coat and allowed to 
differentiate into HMDM for 7 days. HMDM cultures were then infected with WT, P1 and 
P1 (pGPC352) at a MOI of 10:1. The number of bacteria was calculated from the OD 
values obtained and a predetermined standard curve. HMDM infected with bacteria were 
incubated at 37°C for 2hrs. Cells were then washed thoroughly with TC medium (RPMI) 
to remove extracellular bacteria and further incubated at 37oC. At different time points 
(2hrs, 24hrs, 48hrs, 72 hrs and 96hrs) cells infected with all three bacterial strains were 
lysed using 0.1% SDS for 10min, neutralized using 20%BSA and plated on 7H10 agar 
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plates. 7H10 agar plates were incubated at 30°C for 5 days for enumerating colony 
forming units (CFU). The CFU count obtained after 2hrs was considered as time zero post 
infection.  
3.2.11 Flowcytometric Analysis of Cells Expressing EGFP-Rab 
Rab-GFP adenoviral vector infected HMDM, mouse macrophages or mouse dendritic 
cells were washed and collected in tubes. The cells were incubated with antibodies 
specific for markers of macrophages and dendritic cells at concentrations recommended 
by the manufacturer at 4°C for 30min in PBS with 5% FBS. The cells were then washed 
with PBS. Cells were then analysed on a fluorescence activated cell sorter (FACScanTM). 
The results were recorded using software (CELLQuestTM) and expressed as percentage of 
fluorescent cells. 
3.2.12 Trans-Complementation of the Mutant P1 
A 3.8 kb region from M. marinum harbouring the putative pmiA gene was PCR amplified 
using primers P1_1064F1 and P1_8007R2. The PCR product was purified using Qiagen 
PCR purification kit and eluted with 30µl of water. 5µl of the product was electrophoresed 
on a 0.7% agarose gel to verify the product size. This PCR fragment was cloned into XbaI 
and SpeI digested pOLYG plasmid by homologous recombination technique (In-fusion 
cloning kit; See section 2.2.4.1) to yield pGPC352 conferring resistance to hygromycin. 
Plasmid pGPC352 was transformed into electroporation competent P1 mutant cells by 
applying an electric pulse of 2.5Kv. Following electroporation the cells were suspended in 
7H9 medium and incubated at 30°C for 4hrs on a shaker incubator. Then the cells were 
selected on a 7H10 agar plate containing 30µg/ml kanamycin and 50µg/ml hygromycin. 
Colonies were picked from the plates and analysed for the presence of the plasmid 
pGPC352 by a PCR reaction using primers P1_1064F1 and P1_8007R2.  
Nested-deletion DNA fragments were generated from the 3821bp M. marinum fragment 
in pGPC352 using a combination of internal PCR primers. The amplified fragments were 
cloned into pOLYG in the same way as described earlier to yield pGPC369, 370, 371, 
372, 373 and pGPC374 (Fig-3). These plasmids were transformed into the mutant P1 as 
described before for analysis of functional complementation.  
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3.2.13 Radiolabelling of Mycobacterium 
M. marinum WT and mutants were metabolically labelled with [1-14C] palmitic acid by 
growing bacteria in 7H12 medium (BACTEC) containing 1µCi [1-14C] palmitic acid. 
Bacteria were cultured for five days at 30oC before being used for experiments. Phenolic 
glycolipids of mycobacteria were labelled by pulsing a three day old mycobacterial 
culture with [carboxyl – 14C] p-hydroxy benzoic acid (0.7µCi/ml). After pulsing with 
[carboxyl – 14C] p-hydroxy benzoic acid the culture was further grown for another two 
days before it was harvested.  
3.2.14 Quantitative Analysis of Mutants Reaching the Phagolysosmes 
Bacterial cultures were transferred to 15ml centrifuge tubes and centrifuged at 5000rpm 
for 10min. The bacterial pellets obtained were suspended in 5ml TC medium (RPMI) and 
washed by centrifugation at 5000rpm for 10 min. The washing was repeated once again. 
Supernatants were discarded and the pellets resuspended in 1ml of 7H9 broth. To the 
bacterial suspensions a little amount of sterile glass beads was added and the 
mycobacterial clumps were dispersed on a cell mill (Retsch MM2000) for 5min followed 
by centrifugation at 600rpm for 5min to remove the remaining bacterial clumps. The 
supernatants were aspirated and passed through a 27G needle 3 times. The CFU was of 
bacteria was calculated as described previously from the OD measurements and a standard 
curve. The density of the bacterial suspensions was adjusted as required using TC medium 
(RPMI).  
HMDM grown as described previously (see section 3.2.1) were infected with 
radiolabelled bacteria at an MOI of 1:1 and chased overnight into PL along with iron 
dextran beads as PL marker. Following the chase, bacteria present in PL along with the 
iron dextran beads were selected on a MACS column (for a detailed protocol see section 
3.2.2). 100µl of the isolated PL fraction was added to 2ml of scintillation fluid in 
scintillation vials. The scintillation vials were then placed in a β-scintillation counter 
(1217 Rackbeta) to determine the counts per minute (CPM). 
3.2.15 Mice Infection 
Specific pathogen-free C57BL/6 mice were infected intravenously with 4x105 viable M. 
marinum WT, mutants P1 and complemented P1 (pGPC352). At 1 and 2 weeks after 
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infection five mice from each group were sacrificed by cervical dislocation and their liver 
and spleen excised aseptically. Liver and spleen were weighed and small equal samples of 
each liver and spleen were fixed in 4% formaldehyde for histopathology. Remaining liver 
and spleen samples were taken in a mortar and a little amount of white sand was added 
and the organs homogenized with a pestle. 5ml of sterile water was added to the 
homogenized suspension and transferred to a 15ml tube. The homogenized organ 
suspension was centrifuged at 400rpm to remove the tissue debris. The supernatant was 
transferred to another 15ml tube and centrifuged at 5000rpm to pellet the bacteria. The 
bacterial pellet was resuspended in 1ml 7H9 broth. Serial dilutions were made in 7H9 
medium and 20µl of the diluted samples dropped on 7H10 agar plates. The inoculated 
7H10 agar Plates were incubated for 5 days and CFU were counted. 
3.2.16 Mycolic Acid Extraction and Analysis 
3.2.16.1 Solvent Extraction 
Methanolic esters of mycolic acids were prepared from [1-14C] palmitate labelled bacteria. 
Bacteria (WT or mutant) grown in [1-14C] palmitate containing medium were collected in 
15ml tube. To the bacterial pellet 1ml methanol, 1ml 30% aqueous KOH and 0.1ml 
toluene were added. The mixture was incubated at 75oC overnight, was cooled and 
acidified to pH1 by adding 3.6% HCl. Three extractions were performed with 1ml 
petroleum ether each time. The petroleum ether layers were pooled and evaporated to 
dryness by passing over a mild stream of nitrogen. Once dried the mycolic acids were 
methanolated by adding 1ml of Dichloromethane, 1ml catalyst solution (0.8g NaOH and 
3.39g Tetra-n-butyl ammonium hydrogen sulphate in 100ml water) and 25µl 
Iodomethane. The mixture was mixed for 30min and the upper layer was removed and the 
bottom layer dried under nitrogen. The dried fatty acids were dissolved in 3:1 chloroform 
and methanol (Valero-Guillen et al., 1986). 
3.2.16.2 TLC Analysis  
Mycolic acid samples were spotted on a silica high performance thin layer 
chromatography (HPTLC) plates (20x10cm silica gel 60 HPTLC plates). Petroleum ether 
(bp 60-80°C) and Acetone in a 95:5 v/v ratio were used as mobile phase to chromatograph 
the samples. After the mobile phase reached 3/4th of the TLC plate, the plate was removed 
from the chamber, dried and placed in a cassette and an X-ray film was placed over the 
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plate. The cassette containing the plate was left undisturbed for 4 days and then the film 
was removed in the dark and developed using an X-ray film developing machine (Agfa 
Curix60). 
3.2.17 Non-Polar Lipid Analysis 
3.2.17.1 Extraction 
Bacteria were grown in 10ml 7H9 middle brook liquid broth for 5 days. The culture was 
centrifuged at 5000rpm for 10min and the medium was removed. 1ml of methanol – 0.3% 
NaCl (100: 10) was added to the cell pellet. Non polar lipids were extracted from the 
bacterial suspension using petroleum ether (3x 1ml). The petroleum ether extracts were 
pooled and dried under nitrogen. The dried lipid was dissolved in CHCl3 – CH3OH (3:1) 
(Dobson et al., 1985). 
3.2.17.2 Analysis by TLC 
The lipid samples were spotted on a silica HPTLC plate (20x10cm silica gel 60 HPTLC 
plates) and chromatographed using CHCl3 – CH3OH – water (90:10:1) as mobile phase. 
Lipid spots were visualized by dipping the chromatographed TLC plate in a solution 
containing CuSO4 (10%) and 8% perchloric acid or in a solution containing 0.2% 
anthrone in concentrated sulphuric acid (to detect glycolipids) followed by charring at 
180°C over a hot plate (Thermoplate S). 
3.2.18 Extraction of a Lipid Species from WT M. marinum Missing in Mutant P1 
WT M. marinum was grown in 100ml of 7H9 Middle Brook broth for 5 days. The cells 
were harvested by centrifuging at 5000rpm for 10min. The bacterial cells were left in 
CHCl3–CH3OH (2:1 v/v) for 2 days. Then cells were pelletted down by centrifugation and 
the chloroform – methanol supernatant was stored separately from the cells. Cells were 
extracted twice with CHCl3–CH3OH (1:1); each extraction was carried out for 24hrs. The 
extractions were pooled and washed twice with normal saline (0.9% NaCl in water). The 
aqueous layer was removed and the organic layer was dried under nitrogen.  
The extracted lipids were re-dissolved in CHCl3–CH3OH (3:1 v/v) and chromatographed 
on a preparative silica gel TLC plate (20x20cm silica gel 60 TLC plate). CHCl3 – CH3OH 
– water (90:10:1 v/v) was used as mobile phase (Constant et al., 2002). After 
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chromatography staining for the lipids was performed by dipping the sides of the TLC 
plate in a solution containing CuSO4 (10%) and perchloric acid (8%) followed by charring 
at 80°C over a hot plate (Thermoplate S) to visualize the lipid spots. The lipid spot 
corresponding to the lipid missing in the mutant was marked and the corresponding silica 
gel band was scraped off from the unstained region of the TLC plate using a scalpel and 
taken in a 50ml tube. 
The lipid was further extracted from the silica matrix using CHCl3 – CH3OH (1:1 v/v). 
The extraction was performed three times. The pooled extracts were centrifuged at 
5000rpm to remove any silica gel. The extracts were dried under nitrogen and dissolved 
1ml of CHCl3 – CH3OH (3:1 v/v). This solution was transferred to a 1.5ml eppendorf tube 
and centrifuged at 15,000rpm for 2 min to remove any silica particles. The remaining 
solution was transferred to another pre-weighed 2ml eppendorf and dried under nitrogen. 
Once dried the lipid present was weighed and stored at -20°C until use. 
3.2.19 Structural Elucidation of the Lipid Missing in Mutant P1 by Mass and 
NMR Spectrometry 
ESI-TOF (Electro spray ionisation- time of flight) -mass spectra were recorded in positive 
ion mode on a Q-TOF 2 mass spectrometer (Micromass, Manchester, UK) equipped with 
a nanospray source. Analytes were dissolved in chloroform : methanol and were injected 
into the mass spectrometer by glass capillaries using a capillary voltage of 1000 V and a 
cone voltage of 50 V. Instrument calibration was done with a mixture of sodium iodide 
and caesium iodide dissolved in 50% aqueous 1-propanol. 
1H-NMR Spectra were recorded in CDCl3 on a Bruker AMX 500 Instrument at 500 MHz 
3.2.20 Coating of Beads with Mycobacterial Lipids. 
10µl (0.5mg) of RPC-18 beads (Dynal) or fluorescent polystyrene beads were placed in a 
1.5ml eppendorf tube and 500µl 0.1M NaHCO3 buffer pH 9 was added. Beads were 
washed by pipetting up and down carefully and the tube was placed on magnet (Dynal) 
for 2min. With beads captured to the wall next to the magnet, the buffer was removed. 
This procedure was repeated twice. The bead suspension was added to tubes in which 
PGL-1 or PGL-2 lipids were dried (1mg of lipid), followed by sonication in a sonicator 
bath for 10min. The suspension was further incubated at 37oC for 2hrs with intermittent 
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sonication for 5min. The tube containing beads and lipid was placed again on magnet to 
remove buffer. The lipid coated beads were suspended in 1ml of PBS containing 5% BSA 
and incubated at 37oC for 1hr to block the unbound sites of the beads. The lipid coated 
beads were then washed with 1ml of serum free medium (SFM) twice as described above. 
The lipid coated beads were then suspended in 1ml of SFM.  
Fluorescent polystyrene beads were coated with lipid using the same procedure described 
above but the washing of the beads was done by centrifugation at 1200g for 15min instead 
of the magnetic separation. 
3.2.21 Characterisation of Phagosomes Containing Lipid Coated Beads.  
Buffers  
Equilibration Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 1mM DTT and 
 10μM Cytochalasin B. 
Lysis Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 220mM Mannitol; 
 68mM Sucrose. 
Wash Buffer 
50mM Pipes buffer pH7.0; 50mM KCl; 2mM MgCl2; 5mM EGTA; 1mM DTT. 
Elution Buffer  
10mM triethanolamine; 10mM acetic acid; 1mM EDTA; 0.25M sucrose 
HMDM were cultured in TC flasks as described earlier (see section 2.2.1). Cells were 
washed with SFM twice and placed in 2ml of SFM medium. A suspension of 100µl PGL-
1 coated beads, PGL-2 coated beads (prepared as described above), uncoated RPC-18 
beads (hydrophobic) or Myone beads (hydrophilic) was added to the cells in each TC 
flask. Uncoated beads were treated in the same way as coated beads except that no lipid 
was added. Cells with beads were incubated at 37oC in a 5% CO2 atmosphere for 1hr. 
After 1hr cells were washed with SFM three times to remove non-phagocytosed beads. 
HMDM along with beads were further chased by incubating overnight at 37oC in a 5% 
CO2 atmosphere. Macrophages were then washed with PBS once followed by the addition 
of 1.5ml equilibration buffer. The cells were then incubated on ice for 20min before 500µl 
lysis buffer was added. HMDM were then scraped off using a rubber policeman and 
collected in a 2ml eppendorf tube. The collected cell suspension was passed through a 23 
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gauge needle at least 15 times. 100µl of the homogenized cell suspension was kept aside 
for analysis. The eppendorf tubes containing the cell lysate were then placed on a magnet 
stand (Dynal) for 2min. Phagosomes containing the beads were captured on the wall of 
the tube, while the remaining fraction was removed and stored for analysis. The captured 
bead fraction was washed twice with 500µl of elution buffer and was finally suspended in 
200µl of phagosome elution buffer. 
The fractions stored were subjected to western blot analysis (section 3.2.5). After 
transferring the proteins on to PVDF membrane the blots were probed for Rab5 and β-
galactosidase using the respective antibodies. Fluorescent polystyrene beads coated with 
PGL-1 and PGL-2 were chased (as described earlier in this section 3.2.21) into HMDM 
grown on glass cover slips and the cells were marked for different phagosomal markers 
(see section 3.2.8 for protocol) and investigated under a fluorescence microscope. 
3.2.22 Cloning, Expression and Purification of PmiA-Protein 
3.2.22.1 Cloning 
Gene pmiA was amplified from WT M. marinum using primers P1N_pQE18_BD_F1 and 
P1N_pQE18_BD_R2 for cloning into vector pQE10 and primers P1N_pQE10_BD_F2 
and P1N_pQE10_BD_R1 for vector pQE18. The amplified fragments were purified using 
Qiagen PCR purification kit and cloned in frame with the 6X Histidine (His) tag into 
plasmids pQE10 (N-terminal His-tag) and pQE18 (C-terminal His-tag) by homologous 
recombination (In-fusion kit) to yield plasmid pGPC363 and pGPC364 respectively. The 
recombination reactions were transformed into BD-fusion blue cells supplied along with 
the kit (see section 3.2.4). The clones were selected on LB plates containing 50µg/ml 
ampicillin. Clones were picked and analysed for inserts. Clones containing inserts were 
sequenced to confirm the correct fusion of the pmiA ORF to the His tag. Clones C777 
(pmiA in pQE10) and C778 (pmiA in pQE18) were chosen for further use.  
3.2.22.2 Expression 
To express the gene pmiA in E. coli, a 10ml LB broth with 50µg/ml ampicillin was 
inoculated with a colony of C777 and C778 containing the pmiA plasmid and grown at 
37°C overnight. The overnight culture was transferred to a 100ml LB broth containing 
50µg/ml ampicillin and incubated at 37°C until the culture reached an OD of 0.8. E. coli 
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cells were induced by adding 100µl of IPTG (Isopropyl β-D-1-thiogalactopyranoside) and 
further incubated for 3hrs. The cells were harvested by centrifuging for 15min at 
5000rpm. The cell pellets were stored at -80°C until use.  
3.2.22.3 Purification 
Buffers 
Buffer A 
1M NaCl, 10mM Imidazole and 50mM Tris pH 8.0 
To purify the protein the cell pellet was thawed, suspended in 5ml of Buffer A, 300µl of 
lysozyme (40mg/ml stock solution) was added and incubated on ice for 30min. A small 
amount of glass beads of 0.2mm diameter were added and the suspension was agitated on 
a mill for 5min to disrupt the cells. Glass beads were allowed to sediment and the 
supernatant was transferred to another tube and centrifuged for 20min at 10000rpm/min. 
The pellet was suspended in 5ml buffer A containing 1% Zwittergent 3-12, 1mM PMSF 
and incubated for 1hr at 20°C and centrifuged again at 10000rpm for 10min. Pellets were 
stored at -20°C. The supernatant was incubated with 1ml 50% Ni-NTA for 1hr at RT. Ni-
NTA was washed twice with 4ml buffer A containing 1% Zwittergent 3-12 and twice with 
buffer B (same as buffer A but the pH is 6.0) with 1% Zwittergent 3-12. Elution was done 
in a cold room (+4°C). The protein was eluted from Ni-NTA resin using 0.5ml buffer B 
containing 1% zwittergent and 250mM imidazole. Elution was repeated 5 times. The 
amount of protein was estimated using Pierce assay following the protocol of the 
manufacturer. The protein was further analysed on a 10% SDS-PAGE.  
3.2.23 Capturing Proteins Interacting with PmiA. 
3.2.23.1 Preparation of Proteins from Mycobacterial Lysate 
Buffers 
Interaction Buffer 
50mM NaH2PO4; 300mM NaCl; 20mM Imidazole; 0.005% Tween20 and pH adjusted 
to 8.0. 
Wash Buffer 
50mM NaH2PO4; 300mM NaCl; 20mM Imidazole; 0.1% Tween20 and pH adjusted to 
8.0. 
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M. marinum protein whole cell soluble protein solution was prepared from a cell pellet 
obtained from a 5 day old 500ml culture. The liquid culture was centrifuged at 5000rpm 
for 15min to obtain the bacterial pellet. The pellet was suspended in 9ml interaction buffer 
with 1ml EDTA free protease inhibitor cocktail. The cell suspension was distributed into 
eppendorf tubes and a small amount of glass beads was added and agitated on a mill for 
30min to completely disrupt the cells. Unbroken cells and glass beads were removed by 
centrifuging at 600rpm for 5min.  The supernatant was collected and stored at -80°C until 
use. 
3.2.23.2 His-Tag Pull Down Assay 
Native proteins expressed and purified from C777 and C778 were immobilized on to 
magnetic agarose beads by incubating 30µg of protein with 100µl magnetic agarose beads 
in protein binding buffer at 22°C in a hybridization oven. The tubes were then placed on a 
magnet stand (Dynal) to separate the magnetic beads immobilized with protein. The 
supernatant was removed and the beads were washed once with 500µl interaction buffer. 
500µl of M. marinum protein solution was mixed with pmiA protein bound to the 
magnetic agarose beads and incubated for 1hr at 22°C in a hybridization oven. The tubes 
were again placed on a magnet and the supernatant was removed. The beads were washed 
twice with 500µl wash buffer. The agarose beads left in the tube were stored at -20°C 
until use. The proteins interacting with pmiA were analyzed by separating the proteins on 
a SDS-PAGE. His-tag-DHFRS (dihydrofolate reductase) protein (expressed and purified 
from pQE16 plasmid) was used as a negative control in these experiments.   
 
 
 
 
 
 
 
 
   
69
 4  Results 
4.1 Magnetic Separation of Phagolysosomes from Subcellular Components 
In order to isolate phagolysosomal fractions iron dextran micro beads which are proved to 
be delivered to the phagolysosomes were chased into HMDM. HMDM containing iron 
dextran beads were lysed carefully and the cell components were passed through a MACS 
column under strong magnetic field. The cellular fraction that adhered to the magnetic 
column was eluted and further analysed. Experiments were performed to prove that the 
micromagnetic beads reach the lysosomal vacuoles and the isolated fractions were 
phagolysosomes. The isolated PL fraction was subjected to western blot analysis by 
probing with LAMP- 1 and EEA-1 antibody. As expected the PL fraction isolated did not 
contain EEA-1 but LAMP-1 effectively marked the isolated PL fraction as depicted in 
(Fig-3).  
A B C D E F G H I
LAMP1
EEA1
GAPDH
 
Figure 3: Western Blot Analysis of lysosomal fraction recovered by magnetic separation.  
HMDM were pulsed with ‘basic microbeads’ (Miltenyi Biotech) for one hour followed by a chase 
for two hours (lanes D-F) or overnight (lanes G-I); lanes A-C: control macrophages without 
beads. After the chase, macrophages were lysed (lanes A, D, G) and magnetic separation of 
subcellular compartments was done following the same procedure as for the selection of M. 
marinum mutants incompetent in retarding phagosome maturation. Lanes B, E, H: macrophage 
lysate fraction not binding to magnetic column (flow-through). Lanes C, F, I: organelle fraction 
binding to magnetic column in the absence (C) or presence (F, I) of ‘basic microbeads’. 
Following SDS-PAGE and blotting, membranes were probed with LAMP-1, EEA-1 or GAPDH 
antibody and developed by enhanced-chemiluminescence analysis.  
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4.2 Screening for M. marinum Mutants Permitting Phagosome Maturation 
To decipher the mycobacterial genes ascribed to inhibit PM, a screen to isolate Tn5367 
transposon inserted mutants defective in inhibiting PM was established (Fig-4). We 
designed the screen using our own experience that M. marinum can endure the hostile 
phagolysosomal milieu for a long duration (24 hours, data not shown). The screen was 
based on the presumption that mutants disabled to inhibit PM would be enriched in the 
phagolysosome (PL) along with the PL markers. Transposon insertion mutants were 
chased together with magnetic microbeads into the phagocytic pathway of human 
monocyte derived macrophages (HMDM). After an overnight chase the plasma membrane 
of HMDM was lysed under carefully controlled conditions, preserving the intracellular 
organelles. The homogenate containing the subcellular components was then passed 
through MACS columns under a magnetic field which retained the magnetic beads in the 
PL inside the column. The column was next removed from the magnetic field and the 
mutants were eluted along with the PL marker. A β-galactosidase assay of the eluted and 
the flow-through fractions revealed that the eluted fraction was strongly enriched in 
phagolysosomes (Fig-5). The lysosomal fraction was plated on 7H10 agar and incubated 
for five days. Bacterial colonies grown on the plate were scraped off, pooled, carefully 
dispersed to yield a single cell suspension and used to infect a fresh culture of HMDM. 
The selection was repeated three times for further enrichment of mutants allowing PM. 
After the final selection 100 individual colonies were picked for further investigation. 
EE
LE
Lys
rab5
rab7
LAMP-1
Cathepsin D
vATPase
microbeads
 
Figure 4: Screening for mycobacterial mutants permitting phagosome maturation.  
Phagosomal processing of mycobacterial mutants with defects in PM inhibition. EE, early 
endosome; LE, late endosome; WT bacteria will remain in a Rab5-positive vacuole, whereas heat 
killed bacteria and mutants with defects in PM will be processed into a LAMP1-positive, vATPase-
positive and cathepsin D-positive phagolysosome (PL). M. marinum transposon mutant library was 
chased together with magnetic microbeads to the PL and those mutants proceeding to the PL 
were selected on a MACS column under a strong magnetic field. 
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Figure 5: β-galactosidase assay performed with macrophage lysate (MP lysate), flow through 
after passing the lysate through MACS column, the washings of the column and the eluted 
phagosomal fraction for all three selections. 
4.3 Defining Transposon Insertion Sites by Sequence and Southern Blot 
Analysis 
In order to define transposon disrupted regions and to identify independent insertions in 
identical genes or loci, 79 of the 100 mutants selected for their inability to prevent PM 
were analysed by sequencing the transposon inserted locus. Southern blot analysis was 
also performed to confirm that each mutant had only a single transposon insertion and to 
identify mutants with transposon insertions in the same gene (Fig-6). The sequences 
obtained were BLASTed against the available M. marinum sequence database of Sanger 
(www.sanger.ac.uk). Since M. marinum genes are not annotated, a homology search was 
done against the Mycobacterium tuberculosis database available through TIGR CMR 
using the BLASTX function (www.tigr.org). ‘Rv’ numbers are used to represent the genes 
identified. Analysis revealed that the insertions were not spread across the genome (Fig-
5). The most striking feature was that transposon inserted regions in 15 of the mutants 
could not be mapped to the available M. marinum genome database of Sanger, although 
similar genes, albeit with low probability scores were identified in other mycobacterial 
genomes. Interestingly, 50% of the insertions were mapped to genes influencing the 
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constitution of the cell envelope of mycobacteria (Listed in Table-2). The significance of 
the mutations is highlighted by the fact that insertions in the same gene or related genes in 
independent mutants were frequently found. Our results in general describing the diversity 
of mycobacterial genes involved in retarding PM are in accordance with previous reports. 
Genes coding for fadD proteins, transporters and genes of the PE/PPE gene family also 
appeared in our screen as was the case in previous screens (Pethe et al., 2004); (Stewart et 
al., 2005). Interestingly a mutant having a transoposon insertion in a gene involved in 
isoprenol biosynthesis as identified by Pethe et al was also identified through our screen. 
Moreover, we had taken utmost care to disperse bacterial clumps into single bacilli. This 
enabled us to identify genes coding for membrane proteins and secretory proteins. Under 
representation of such proteins in genetic screens has been speculated to be due to cross 
presentation by Stewart et al. Our screen also identified genes contributing to the 
resistance of mycobacteria to the killing by macrophages as reported by others 
independently (Sassetti and Rubin, 2003); (Miller and Shinnick, 2001); (Gao et al., 2004); 
(Raynaud et al., 2002); (Haydel and Clark-Curtiss, 2006); (He et al., 2003) (see Table-2 
for details). 
Table – 2: List of Mutants obtained through the screen, their putative function and 
their M. tuberculosis homologue. 
mutant putative function 
Mtb H37Rv 
hom. 
N68 mmpL4 Rv0450c  
N4R mmpS4 Rv0451c 
N43 chorismate pyruvate-lyase Rv2949c  
N33 fadD22, Probable Acyl-CoA Synthetase Rv2948c  
N8 hypothetical protein Rv1259 Rv1259 
N93 PPE family Rv0355c 
N29 PPE family Rv1918c  
N67 galT gal-1-P uridylyltransferase Rv0618 
N34 POSSIBLE TRANSMEM-BRANE PROTEIN Rv0514 
N69 hypothetical protein Rv1134 Rv1134 
N95 hypothetical protein Rv0007 Rv0007 
N21 PPE family Rv1918c 
N10 PPE family Rv1918c 
N61 PPE family Rv2356c  
N32 hypothetical protein Rv0326 Rv0326 
N47 hypothetical protein Rv3829c Rv3829c 
P3 PPE family Rv1548c 
N5 PPE family Rv1135c 
N75 PPE family Rv1135c 
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N76 Unknown function Rv0213c 
N77 Unknown function Rv0213c 
N27 unknown function Rv3897c 
N40 cell division protein ftsh Rv3610c 
N66 unknown function Rv0365c 
N6 unknown function Rv0365c 
N9 unknown function Rv0365c 
N15 unknown function Rv1735c 
N13L PE_PGRS family Rv3388 
N70 hyp. prot. toxin prod & resist. Rv2959c 
N28 unknown function Rv1776c 
N48 hyp. protein, electron transport Rv1882c 
N45 possible transmem. prot. Rv1888c 
N30 unknown function Rv0037c 
N16 PPE family Rv1918c  
N37 rnhB, ribonuclease HII Rv2902c 
N71 unknown function Rv1111c 
N78 hyp. prot. metalloendopeptidase Rv1977 
N18 possible membrane protein Rv0677c 
N81 PE_PGRS family Rv3652  
P1 unknown function Rv2229c 
N100 hyp. prot. stress response Rv2624c 
N39 unknown function Rv0004 
N13R PE-PGRS family protein Rv3812  
N24 fadD22 Acyl-CoA Synthetase Rv2948c 
N63 polyketide synthase Rv0405 
N20 hyp. prot. helicase activity Rv1179c 
N64 unknown function Rv0538 
N84 fadE25 acyl-coA dehydrogenase Rv3274c 
N83 fadD35, Acyl-CoA Synthetase Rv2505c 
N14 unknown function Rv1291c  
N44 PPE protein family Rv3533c 
N82 unknown function Rv0841c 
N65 hyp. prot Cell envelope Rv1145 
N22 cell envelope, toxin production Rv1115 
N73 PGRS family Rv0335c  
N97 hyp. prot. cell envelope Rv1057 
N23 unknown function Rv2347c 
N99 Transport and binding proteins Rv3239c  
N12 Cysteine synthase/cystathio-ninebeta-synthase Rv1336  
N74 ompATb Rv0899 
N38 plcB: phospolipases C Rv2350c 
N92 bifunctional short chain isoprenyl diphosphate synthase Rv3398c  
N4L unknown function Rv3860 
N36 hyp. prot. cell envelope Rv3881c 
N1 hypothetical phage protein spyM18_0725  
N2 unknown function no homology 
N19 prob. cyclase histidine biosynthesis Rv1605 
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N3 hyp. prot. transport Rv0849 
N31 unknown function no homology 
N35 hyp. prot. transport Rv0849 
N41 putative transporter Nocardia pnf1810 
N42 peptide synthetase Rv0101  
N46 unknown function Rv2100 
N62 hyp. prot. fatty acid and phospholipid metabolism Rv2800 
N7 unknown function no homology 
N72 unknown function Rv0523c 
N91 unknown function Rv1944c 
N94 unknown function Rv3668c 
 
 
Figure 6: Southern blot analysis of M. marinum transposon mutants. DNA was isolated from 
mutants separated on agarose gel, transferred onto nitrocellulose membrane and hybridized to an 
aph gene. Lanes 6, 8 and 11 show mutants having transposon insertion in the same gene.  
 
           1     2   3  4  5  6  7  8  9 10  11   12   13    14   
10Kb 
8Kb 
6Kb 
5Kb 
4Kb 
3.5Kb 
3Kb 
Hit within 500bp distance
Hit within 5000bp distance
Hit within 10000bp distance
No strict homology found in M. marinum M strain genome 
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Figure 7: Distribution of selected mutants on the M. marinum M strain genome map. 
Transposon insertion sites and genomic locations were determined by sequencing and BLAST 
analysis (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/m_marinum). 
4.4 Adenoviral Vectors to Track the Endocytic / Phagocytic Pathway 
Rab5 and Rab7 Green fluorescent protein constructs were received from Dr. Craig Roy 
and Rab11 GFP construct was received from Dr. Marci Scidmore. These genes were re-
cloned and packed into an adenoviral vector. Adenoviral vectors harbouring the Rab-GFP 
fusion proteins were used to transfect HMDM. An efficient transfection in HMDM was 
achieved with an MOI of 100:1 when the cells were spin infected. The cells were scanned 
under a fluorescence microscope. Cells expressing GFP were also quantified by FACS 
(Fig-9). In order to confirm that the Rabs were expressed as GFP tagged proteins, western 
blot analysis was performed. The blots were probed with an anti-GFP antibody followed 
by ECL detection. Analysis proved that the Rab-GTPases were expressed as GFP-fusion 
proteins as shown in figure (Fig-8) 
The functionality of the Rab GTPases was assessed by chasing fluorescent dextran and 
transferin (Tf) in HMDM transfected with respective Rab-GFP adenoviral vectors, 
followed by evaluation under a fluorescent microscope. When fluorescent dextran was 
chased for 2 minutes followed by fixation, vacuoles containing dextran were marked by 
the presence of Rab5-GFP indicating early endosomes (Fig-9), whereas in Rab7-GFP 
transfected HMDM, dextran chased for 30min was present in compartments marked with 
Rab7-GFP signifying late endosomes (Fig-9). Similarly Rab11-GFP marker for recycling 
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endosomes was present in organelles containing Tf, when Tf was chased in HMDM for 5 
minutes (Fig-9). These observations ascertain that the Rab-GFP fusion proteins expressed 
in HMDM using adenoviral transfections were functional or at least co-localised with the 
functional wild-type proteins. The same was also confirmed in mouse DCs and 
macrophages (Fig-9). 
 
Figure 8: HMDM were transfected with Rab5 (I: A-C), Rab7 (I: D-F), Rab11a (I: G-IRab11b (II: A-
C) adenoviral constructs for different time points (overnight, 48hrs and 72 hrs). Following 
transfection, cells were lysed and equal amounts of protein was loaded on SDS-PAGE. Gel was 
blotted onto PVDF membrane and probed with antibody against GFP. Cell lysate from cells 
transfected with an empty adenoviral vector (II: D-F) and macrophage lysate (II: G-I) without 
adenoviral transfection were used as negative controls. 
 
Fig 9: FACS analysis of Rab-GFP fusion transfected cells 
Mouse macrophages, Mouse dendritic cells and HMDM were transfected with Rab-GFP 
adenoviral constructs by spin and without spin infection and analysed by FACS. Black curve 
indicates transfection by spin, grey curve indicates transfection without spin and dotted lines 
indicate non-transfected cells. Numbers over the histogram indicate percentage of cells 
transfected by spin/ percentage of cells transfected without spin. 
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Figure 10: Functional characterisation of adenoviral Rab constructs by fluorescent microscopy 
Mouse dendritic cells, macrophages and HMDM were transfected with Rab-GFP adenoviral constructs 
and chased with dextran and transferin. Fig depicts co-localisation of dextran with Rab5-GFP after a 
5min chase (A-C), Transferin (Tf) with Rab11b-GFP after a 5min chase (D-F) and Dextran with Rab7-
GFP after a 30min chase (G-I) 
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4.5 Immunofluorescence Microscopy of HMDM Infected with Mutants  
We employed the above described Rab5- and Rab7-GFP fusion proteins and LAMP-1 
antibody staining to characterize the wild-type M. marinum (WT) and mutant containing 
phagosomes. Immunofluorescence micrographs revealed that WT containing phagosomes 
were indeed found to retain Rab5 (Fig-11A) even after an overnight chase, whereas 
LAMP-1 (Fig-11C) and Rab7 (Fig-11E) were excluded. In contrast, phagosomes 
containing mycobacteria were observed to co-localise with Rab7 and LAMP-1 (Fig-11F 
and 11D). One of the six randomly selected mutants screened (P1) had severely reduced 
capacity to resist PM. 69 + 4% of the P1 phagosomes acquired Rab7  and 73 + 3% 
LAMP-1  compared to 13 + 2%, 22 + 2% respectively of WT bacteria, when 100 
phagosomes of WT and P1 mutant were enumerated each (see Fig–12 and table-3 for 
details). This indicated that the interrupted gene in this mutant has a vital function in 
preventing PM. The gene has been given the provisional name phagosome maturation 
inhibition A (pmiA). 
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Figure 11: Phagosome-phenotypic characterization by fluorescence microscopy. 
HMDM expressing Rab5-GFP (A and B) and Rab7-GFP (E and F) were infected with WT and 
mutant P1labelled with TRITC and observed for co-localisation of the mycobacterial phagosome 
with the phagosomal markers. LAMP-1 staining was done on HMDM infected with WT and 
mutant P1 labelled with FITC (C and D). Phagosomes containing mutant P1 co-localise with 
late endosomal markers Rab7 and LAMP-1 (D and F) but do not co-localise with the early 
endosomal marker Rab5 (B) whereas phagosomes containing WT do not co-localise with the 
late endosomal markers(C and E) but co-localise with Rab5 (A). 
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Figure 12: Analysis of co-localisation data of WT and mutant M. marinum with endocytic markers. 
Values indicate the means and standard deviations of percentages of phagosomes containing 
WT- , P1- and complemented P1[pGPC352] M. marinum co-localised with LAMP-1 (white boxes), 
Rab7 (black boxes) and Rab5 (grey boxes). Data are the mean of three independent experiments, 
with a minimum of 100 phagosomes counted per experiment for each sample.  
Table-3: p values of percentage bacteria co-localising with phagosomal markers 
  WT P1 P1[pGPC352] 
  Lamp-1 Rab7 Rab5 Lamp-1 Rab7 Rab5 Lamp-1 Rab7 Rab5 
P1 <0.001 <0.001 <0.001 - - - <0.001 <0.001 <0.001 
P1[pGPC352] 0.138 0.165 0.576 redundant - - - 
Statistical analyses of data from each time point were performed by one-way ANOVA post hoc range 
test and pairwise multiple comparisons with Tamhane's T2 corrections assuming nonequal variances. 
P-values are indicated. 
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4.6 Mutant P1 is Attenuated in HMDM  
Our results prove that the WT was able to multiply in HMDM. WT M. marinum did not 
grow well nor was there a drastic cell death until day three. This observation is in 
correlation with the recent study by Kent et al (Kent et al., 2006). After 72hrs a rapid 
increase in multiplication of WT was observed, whereas the virulence of the mutant P1 
was severely attenuated in HMDM. After a slight increase during the first 24hours a rapid 
decrease in viability of the mutant P1 was observed. By contrast the complemented 
mutant P1(pGPC352) had a similar growth pattern to that of the WT (Fig-13). Decline in 
the survival of the mutant was as expected and could be attributed to the defect in the 
inhibition of PM. Although a significant reduction in growth of P1 was observed in 
HMDM, P1 growth in 7H9 broth was not inhibited, as shown in Fig-14 neither was a 
growth difference between P1 and WT observed on 7H10 agar medium. 
 
Figure 13: Survival of M. marinum WT, P1 and P1(pGPC352) in human monocyte derived 
macrophages. Macrophages were infected with a MOI of 10:1, incubated at 37oC and lysed for 
CFU counting at indicated time points. The graph shows the mean values of two independent 
experiments with duplicate determinations of each time point in each experiment. Error bars 
indicate the standard deviation.  
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Figure 14: Growth of mutant P1 and WT M. marinum in 7H9 broth.  
7H9 broth was inoculated with WT or mutant P1 and at different time interval OD was measured 
and the values plotted. 
4.7 Bioinformatics Analysis of Transposon Inserted Gene of Mutant P1 
Sequencing of the transposon insertion site in the P1 mutant showed that the transposon 
had inserted in a gene for which the function has not been described. The insertion site 
was mapped to a sequence highly similar (97% sequence identity) to ORF MM3386 in the 
M. marinum ATCC BAA-535 genome. Neither the putative peptide sequence of 203 
amino acids of M. marinum ATCC 729 nor the putative 197 amino acids of MM3386 
were found to have significant similarities to genes in any other genome in the current 
databases (NCBI, EBI and TIGR-CMR). No signature patterns, domains, repeats, motifs 
or other features could be predicted with confidence except for a RGD motif in the 
putative peptide sequence using the latest SMART (Simple Modular Architecture 
Research Tool) at EMBL, the latest BLAST engines at NCBI or the latest releases of the 
PROSITE search engine at http://www.expasy.ch/tools/scanprosite. RGD is the single 
letter code for arginine-glycine-aspartate. This tripeptide motif is normally found in 
proteins of the extracellular matrix. Since the mutant disrupted in this gene is unable to 
inhibit phagosome maturation the gene was named pmiA (phagosome maturation 
inhibition). Downstream to the gene pmiA are putative hydroxylase and carboxylase genes 
with opposite polarity, which could possibly be involved in fatty acid metabolism (Cole et 
al., 1998). A sketch of the organisation of the genes is shown in figure (Fig-15).  
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Figure 15: Physical map of pmiA (MM3386) in M. marinum ATCC 729 and the adjacent putative 
hydrolase (MM3387) and carboxylase (MM3388) genes. The numbering of the ORFs relates to 
the M. marinum ATCC BAA-535 strain sequenced at the Sanger Institute. The M. marinum 
ATCC 729 chromosomal fragments cloned in this study for complementation analysis of the 
mutation in mutant P1 are indicated in shaded bars below the gene graphs. The Genbank 
accession number is indicated.  
4.8 Trans-complementation of P1 and Co-elution of 14C Labelled Bacterial 
Cells with Lysosomal Marker  
The region spanning the transposon insertion site was cloned into a pOLYG shuttle 
vector, electroporated into P1 and selected on plates containing hygromycin and 
kanamycin. To examine whether the reconstitution of the disrupted gene restored WT 
phenotype, HMDM were infected with 14C palmitate labelled bacteria (WT, WT heat 
killed, P1 and P1[pGPC352]) then  pulsed and chased with  marker for phagolysosome 
(PL) and selected on MACS column under magnetic field as performed for transposon 
mutant screen. Bacteria that co-elute with the PL marker were quantified on a β-
scintillation counter. As shown in figure (Fig-16) the majority of the heat killed 
M. marinum co-elute with the PL marker, whereas only a minor fraction of the WT co-
elute with PL. In control a significant fraction of P1 was observed to co-elute with the PL 
marker whereas the trans-complemented P1[pGPC352] and P1[pGPC374] were restored 
to WT levels. We could infer from these observations that the mutant P1 was not 
competent enough to resist PM and when reconstituted with the respective gene was able 
to regain its lost phenotype. To narrow the range of genes affected by the transposon 
insertion and responsible for the phenotypic change in P1, a set of nested deletions in the 
Genbank accession number DQ792981 
3997 bp
pGPC352
pGPC373
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complementation plasmid was generated. The range of WT chromosomal sequences 
covered by the nested plasmids is also shown in figure (Fig-15). Plasmid pGPC374 
harbouring just 1332 bp of WT sequence spanning pmiA and no other putative 
mycobacterial ORF is sufficient to restore the WT phenotype as less than 5% of P1 
bacterial cells harbouring this plasmid co-eluted with the PL marker. These results 
confirm that the transposon interrupted gene pmiA itself is responsible for the inhibition of 
PM and eliminates the involvement of any polar effects on the neighbouring genes. 
 
Figure 16: Co-elution of bacterial cells with lysosomal marker. 
M. marinum WT, mutant P1 and complemented mutant P1[pGPC352] were metabolically 
labelled with 14C palmitate. HMDM were infected with live strains and with heat killed wild-type 
(WTHK) as indicated. Macrophages were pulsed and chased with lysosomal marker (micro 
beads). Subcellular homogenate was applied to a MACS column under a strong magnetic field. 
After removing non-specifically retained organelles by washing the phagosomes containing 
lysosomal marker were eluted. The fraction of bacteria that co-eluted along with the PL marker 
were quantified on a β-scintillation counter. The values above the columns denote the 
percentage of cells co-eluting with lysosomal marker. 
 
 
 
 
 
bacterial strain
86.05
6.03
34.4
5.8 4.9
0
10
20
30
40
50
60
70
80
90
100
WT P1 P1[pGPC352] P1[pGPC374] heat killed WT
pe
rc
en
ta
ge
C
P
M
pe
rc
en
ta
ge
C
P
M
 
   
85
4.9 In vivo Survival of P1 in Mice 
The ATCC 927 M. marinum strain used in this study has been shown to be able to cause 
systemic infection in mice (Kent et al., 2006). Therefore a mouse model was used to 
evaluate the efficiency of the mutant P1 to survive in vivo. C57BL/6 mice were 
intravenously challenged with WT, P1 and P1[pGPC352]. Mice were sacrificed one and 
two weeks post infection and the number of bacteria in spleen and liver were determined 
(Fig-17A and 17B). Analysis of colony forming units recovered from infected mice by 
one way ANOVA for liver and spleen and each week separately showed that the capacity 
to maintain viable bacterial cells in the infected organs was significantly diminished in the 
mutant P1 compared to both WT and P1[pGPC352]; p-values, p < 0.004 for livers first 
and second week, p < 0.001 for spleens first week and p < 0.011 for spleens second week. 
In accordance with previous findings M. marinum WT undergoes a steady decline in 
viability, which was significantly more rapid in P1 infected animals. This is attributed to 
the loss of virulence in P1.  
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Figure 17: In vivo survival of M. marinum mutant P1 in mice. 
C57BL/6 mice were challenged intravenously with an inoculum of 4 x 105 CFU per mouse of M. 
marinum WT, P1 and P1[pGPC352]. After infection, liver and spleen were excised, 
homogenized and the homogenate diluted and plated on 7H10 agar. Box plots of liver and 
spleen CFUs recovered from livers and spleen of 5 mice for each time point infected with WT, 
P1 and P1[pGPC352] are shown. The symbol (*) indicates an 'extreme' value and the symbol 
(Ơ) an 'outlier'. 
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4.10 Histopathology of Infected Organs 
Mycobacterium marinum mutant P1 showed significantly reduced pathological changes in 
C57BL/6 mouse livers. The capacity of P1 to induce granuloma formation was clearly 
attenuated, as the number and extent of the epitheloid granulomas was reduced in the 
mutant in comparison both to the WT and P1[pGPC352], especially in the second week. 
However, P1[pGPC352] infected animals demonstrated a more variable number of 
granulomas than WT. The majority of the granulomas were developed in the lobules and 
fewer in the portal tracts. Granulomas in P1 infected animals also showed more and 
stronger signs of inflammation around the granulomas; i.e. mainly lymphocytes and few 
granulocytes. A striking feature of the liver sections of WT and P1[pGPC352] infected 
animals was the severe endothelialitis which was only marginal in P1 infected animals 
(Fig.-18). One of the five WT infected livers was entirely necrotic with widespread 
hepatocyte damage. Necrosis in the granulomas was observed in none of the animals in 
the other groups. The spleens demonstrated pathological changes to a lesser extent. In the 
second week the red and white pulp of the spleen of WT infected showed in two out of 
five animals very few granulomas, in two out of five none and in one animal the entire 
spleen was necrotic. Among the P1[pGPC352] infected animals five out of five spleens 
demonstrated few small granulomas in the white pulp. In contrast, the P1 infected animals 
showed normal histology and no granulomas except in one animal. 
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Figure 18: Representative micrographs of the histopathology of infected organs. Magnification 
of each panel is 400X. Granuloma morphology in M. marinum-infected C57BL/6 mice. Mice 
were intravenously infected with 4 x 105 CFU of M. marinum WT, P1, P1[pGPC352] and 
sacrificed 2 weeks post infection. Liver sections were stained with HE. (A) and (B) large 
epithelioid granulomas in a WT-infected and in a P1[pGPC352]- -infected mouse. (C) Smaller, 
less well organized granulomas in P1-infected mouse. (D) and (E) endothelialitis in a WT and 
P1[pGPC352] -infected mouse. (F) Signs of endothelialitis absent in a P1-infected mouse 
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4.11  Non-Cording Phenotype and Lipid Profile 
Unexpectedly, P1 when recovered from the organs of mice produced flat, smooth and 
transparent colonies. WT bacteria retained their rough colony morphology and the 
complemented P1[pGPC352] reverted back to WT morphology to a greater extent (Fig-
19), confirming that the altered colony morphology of P1 was due to the disruption of the 
gene pmiA. We investigated whether the mycolic acid profile of P1 was altered. The 
mycolic acid patterns were as described before and no significant differences were 
observed in P1 when compared to that of the wild-type (Fig-20). Hence we undertook a 
more systematic approach to study lipid profiles as explained by Dobson et al (Dobson et 
al., 1985). When highly hydrophobic outer layers of lipids were extracted using petroleum 
ether and analysed on TLC a lipid moiety in WT could be resolved, which was missing in 
the mutant P1 and was restored in the complemented P1[pGPC352] (Fig-21).  These 
results indicate a function for the gene pmiA in lipid metabolism or transport.  
 
Figure 19: Colony morphology of mutant bacterial cells. 
Bright field microscopy of M. marinum WT-, P1- and P1[pGPC352]-colonies; 7 days after 
recovery from mouse organs and seeding onto 7H10 agar. After passage through mouse 
organs P1 produced flat, smooth and translucent colonies. P1[pGPC352] regained WT 
characteristics to a greater extent. The scale bar in all images is equal to 0.1 mm. 
WT P1 P1[pGPC352] 
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Figure 20: Mycolic acid profile of WT and mutant P1. 
Mycolic acids were extracted from WT and mutant P1 labelled with 14C palmitate and 
chromatographed on a TLC plate. Fig shows the different mycolic acids present in WT and mutant 
P1   
 
Figure 21: Lipid profile of mycobacterial cell wall.  
Non-polar lipids non-covalently bound to the cell wall of M. marinum WT, P1 and P1[pGPC352] 
were isolated using petroleum ether and separated by thin layer chromatography (TLC). The 
chromatogram was developed by treating with phosphoric acid followed by charring. The black 
arrow indicates a lipid fraction present in WT and P1[pGPC352] but missing in the mutant P1.  
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4.12   Characterization of the Lipid Missing in Mutant P1 
The lipid absent in mutant P1 was purified from a lipid extract of WT using preparative 
TLC. The purified lipid was subjected to electrospray mass spectrometry (ES/MS). This 
analysis revealed a series of sodiated molecular ion peaks at 1516, 1530, 1544, 1558, 
1572, 1586, 1600, 1614 m/z (Fig-22). The same peaks were also observed in a study 
where two of the  three terminal sugars were truncated by knocking out a gene involved in 
glycosylation of phenolic glycolipid (PGL) (Perez et al., 2004). It is also know from 
earlier studies that PGL of M. marinum is 3-O-methyl rhamnose glycosylated 
phenolphthiocerol.  In order to further confirm the nature of the sugar, PGL was subjected 
to mild acid hydrolysis and the sugar and the lipid moieties were separated on a 
preparative TLC plate. The sugar moiety was extracted, purified and analysed by MS. A 
peak was observed at 191m/z (Fig-24) which corresponds to the mass of the predicted 
sugar moiety. Using the structure derived from ES/MS analysis, a NMR spectrum was 
predicted for PGL using ChemDraw® 8.0 (Cambridgesoft Corp.). The NMR spectrum 
obtained (Fig 25B) from the purified PGL matched with that of the predicted spectrum 
(Fig-25A). Two unshielded doublets were observed at 6.97 and 7.10ppm corresponding to 
the proton resonance of the phenolic group of PGL-1. At least two singlets were observed 
in the region of the resonances of OCH3 protons linked to the sugar moiety between 3.5 
and 3.6ppm. A signal at 1.25 ppm corresponding to the polymethylenic CH2 units was 
also noted. The resonances of the terminal CH3 protons were observed at 0.8-1.00 ppm. 
Also the resonance of the methine (CH) proton of the esterified β-glycol and the methoxy 
group of phenolphthiocerol were observed at 4.83 and 3.32 ppm respectively (Perez et al., 
2004). From these observations the chemical structure of PGL-1 was derived (Fig-23). 
The lipid missing in the mutant P1 was also characterized biochemically. WT and P1 
mutant were grown in liquid broth pulsed with [14C] palmitate or [14C] p-hydroxy benzoic 
acid, a known precursor of PGL. The lipids of the membrane and the cytoplasm were 
extracted separately from the bacterial pellet following a previously described protocol 
(Sulzenbacher et al., 2006).   [14C] palmitate labelled cells showed up many lipids of the 
outer envelope and the inner cytoplasm except for one lipid spot missing in the mutant P1 
(Fig-26). When labelled with [14C] p-hydroxy benzoic acid, very clearly only one lipid 
spot corresponding to the missing lipid spot of the mutant P1 was found to co-migrate 
with the M. marinum specific lipids labelled with [14C] palmitate. This radioactive species 
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was again absent in the mutant P1 (Fig-27), confirming that the lipid contains a p-hydroxy 
benzyl moiety. These data collectively prove that the missing lipid spot in mutant P1 is a 
PGL.  
 
 
 
 
 
 
 
Figure 22: Mass spectrum of the lipid missing in mutant P1. 
The lipid spot missing in mutant P1 was purified and subjected to ES/MS analysis. The figure 
represents the mass speaks corresponding to that of phenolic glycolipid. 
 
Figure 23: Chemical structure of the characterized Phenolic Glycolipid of M. marinum. 
The chemical structure was derived from the mass values obtained from ES/MS analysis.  
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Figure 24: Mass spectrum of the sugar component of PGL-1 
PGL-1 was subjected to acid hydrolysis to yield the sugar. The sugar moiety was purified from a 
preparative TLC plate and subjected to MS analysis. The figure shows a mass peak at 191.2 m/z 
corresponding to that of the sugar moiety present in PGL-1.  
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Fig – 25 B: Obtained NMR spectra of PGL-1 
Fig – 25 A: Predicted NMR spectrum of PGL-1 
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Figure 26: TLC profile of lipids of WT and mutant P1 
Lipids were extracted from WT and P1 grown in 7H12 medium containing 14C palmitic acid and 
chromatographed on TLC. Arrow indicates PGL-1 found missing in mutant P1 
 
 
Figure 27: Lipids of WT and mutant P1 labelled with 14C p-hydroxybenzoic acid 
WT and mutant P1 were grown in 7H9 medium pulsed with 14C p-hydroxybenzoic acid and lipids 
extracted and chromatographed on TLC plate. Arrow indicates PGL-1 of WT labelled with 14C p-
hydroxybenzoic acid whereas it is absent in mutant P1. 
PGL
WT P1
PGL
WT                    P1  
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4.13  M. marinum PGL Inhibits Phagosome Maturation 
The mutant P1 was unable to inhibit PM and failed to synthesise PGL. PGL analysis by 
radioactive labelling and TLC were also performed with other mutants (N33, N43, N68 
and N70) obtained through the screen. These mutants had transposon insertions in genes 
involved or possibly involved in PGL biosynthesis. Interestingly these mutants also failed 
to produce PGL. Therefore, we asked if PGL on its own could inhibit PM. To prove this 
hypothesis, PGL purified from M. marinum was coated on to fluorescent polystyrene 
beads which were then chased in HMDM overnight. As controls uncoated beads and 
beads coated with a lipid migrating below the PGL on TLC which is also present in the 
mutant were chased in HMDM separately. Following the chase the cells were stained for 
LAMP-2 and Rab5 and viewed under a fluorescence microscope. As expected higher 
percentages of phagosomes containing plain beads and control lipid coated beads were 
LAMP-2 positive compared to that of PGL coated beads. In contrast, phagosomes 
containing PGL-1 coated beads contained Rab5 as demonstrated by immunofluorescence 
microscopy (Fig-28). 
To further prove that M. marinum PGL inhibits PM, hydrophobic magnetic beads coated 
with PGL or control lipid, uncoated beads and hydrophilic magnetic beads were chased 
into HMDM and, using the same protocol used to isolate mutants ending up in the 
phagolysosomes, the cells were lysed and the phagosomes containing magnetic beads 
were isolated under a magnetic field. The isolated fractions were subjected to western blot 
analysis. Following electrophoretic transfer to polyvinylidene difluoride (PVDF) 
membrane, this was probed with antibody against Rab5 and β-galactosidase and further 
detected by electro-chemiluminescence (ECL) analysis. This revealed that the phagosomal 
fraction containing PGL coated beads were highly reactive with Rab5 antibody compared 
to that of the controls (Fig-29), denoting that the PGL coated beads are held up in an early 
endosome like phagosome. By contrast PGL phagosomal fraction did not react with anti-
β-galactosidase antibody. These results indicate that M. marinum PGL is capable of 
inhibiting PM on its own. Moreover, a defect in the biosynthesis of PGL by the mutant P1 
could be contributing for its inefficiency in restricting PM. 
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Figure 28: Characterization of phagosomes containing PGL-1 coated beads by fluorescence 
microscopy. 
PGL-1-, control lipid-coated and uncoated fluorescent beads were chased into HMDM overnight 
and stained for PL marker LAMP-2 (A-C) and early phagosomal marker Rab5 (D-F). 
phagolysosomes containing PGL-1 coated bead stained for LAMP-2 but did not stain for early 
phagosomal marker Rab5 (F), whereas phagosomes containing uncoated beads and control lipid 
coated bead stained for LAMP-2 (A, B) but did not stain for Rab5 (D, E). 
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Figure 29: Western blot analysis of phagosomes containing PGL-1 
Hydrophobic magnetic beads were coated with PGL-1 and chased into macrophages followed by 
isolation of phagosomes containing beads, which were lysed and separated on a SDS-PAGE, 
transferred on to PVDF membrane and probed with anti-β galactosidase and anti-Rab5 
antibodies. 
A- Macrophage lysate 
B- Phagosomes containing plain beads 
C- Lysate of macrophages chased with beads coated with a lipid of mycobacteria also present in 
mutant P1. 
D- Phagosomes containing beads coated with a lipid of mycobacteria also present in mutant P1     
E- Lysate of macrophages chased with beads coated with PGL-1 
D- Phagosomes containing beads coated with a PGL-1 
 
4.14  Functional Characterization of the Gene pmiA 
Database search using the available search engines and analysis of the gene sequence and 
the predicted protein sequence using bioinformatics tools as described above did not 
return significant hits. Therefore, to study the involvement of gene pmiA in the 
biosynthesis of PGL an attempt was made to identify its binding partner proteins if any. 
The protein PmiA was expressed as a histidine fusion protein immobilized on magnetic 
agarose beads. These beads were used to pull out the interacting partner(s) of PmiA from 
a lysate of mycobacterial proteins. As a control DHFRS-His tag protein was expressed 
from a plasmid immobilized on to magnetic agarose beads and allowed to bind with 
mycobacterial proteins. Proteins bound to the beads were resolved on SDS PAGE. 
Interacting proteins specific for pmiA were excised from SDS PAGE gel and were given 
for mass finger printing (Fig-30). Interestingly, MALDI-MS results unveil the pmiA 
interacting proteins to be a methyl transferase and isocitrate lyase. A similar methyl 
Anti-ß galactosidase
Anti-Rab5
A B C D E F
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transferase has been earlier shown to be responsible for the cyclopropanation of mycolic 
acids, major fatty acids of mycobacterium species. Isocitrate lyase is considered important 
for the glyoxylate shunt pathway used by M. tuberculosis during its period of latency, in 
order to derive its energy through fatty acid metabolism. These results, though 
preliminary, substantiate the role of PmiA in lipid biosynthesis. 
 
Figure 30: SDS-PAGE showing proteins possibly interacting with PmiA 
PmiA was expressed as his-tag fusion protein, bound to magnetic agarose beads and allowed to 
interact with slurry of mycobacterial proteins. The proteins bound to PmiA were separated on 
SDS-PAGE.  
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 5  Discussion 
5.1 Mycobacterial Genes Possibly Involved in the Inhibition of Phagosome 
Maturation 
Virulent mycobacteria hijack macrophages and interfere with the intracellular signalling 
to reside within a specialised phagocytic compartment. In order to understand the genes 
contributing to the inhibition of PM, we performed a screen to select for the transposon 
inserted M. marinum mutants localising in the PL. Although many genetic approaches 
have been used to elucidate the mechanisms of mycobacterial pathogenesis, studies using 
mutant strains are considered to be more effective than other strategies (Murry and Rubin, 
2005). Investigations using transposon mutant pools have been successfully used by 
different groups to examine genetic needs for mycobacterial virulence in vivo in mice, 
survival in macrophages, to identify genes involved in arresting PM and acidification of 
phagosomes. Are there multiple genes involved in the inhibition of PM? Using our screen 
we identified genes related to lipid and protein metabolism, transport, cell wall associated 
proteins, genes belonging to PE/PPE (Proline-Glutamine / Proline-Proline-Glutamine 
domains) gene family and many unknown or hypothetical genes, implying diverse and 
multiple genetic requirement. Identification of mutants with insertions in genes involved 
in isoprenoid biosynthesis pathway by us and Pethe et al. indicates the extent of 
biochemical machinery employed by mycobacteria to facilitate the inhibition of PM 
(Pethe et al., 2004).  
5.1.1 Genes Belonging to PE/PPE Gene Family 
Identification of genes belonging to the PE/PPE gene families has been a common feature 
in different genetic screens done to study different aspects of mycobacterial pathogenesis 
and our screen is not an exception. This family of genes is remarkable in that it is 
composed of 100 homologous genes only in mycobacteria (Brennan and Delogu, 2002). 
The PE and PPE gene families of M. tuberculosis encode large multi-protein families (99 
and 69 members respectively) of unknown function. These protein families comprise 
about 10% of the coding potential of the genome of M. tuberculosis. The PE family is 
characterized by the presence of a proline-glutamic acid (PE) motif at positions 8 and 9 in 
a much conserved N-terminal domain of approximately 110 amino acids. Similarly, the 
PPE family also contains a highly conserved, but unique, N-terminal domain of 
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approximately 180 amino acids, with a proline-proline-glutamic acid (PPE) motif at 
positions 7–9. Although the N-terminal domains are conserved within each family, there 
is very little N-terminal homology between the two different families. The C-terminal 
domains of both of these protein families are of variable size and sequence. They also 
frequently contain repeat sequences of different copy numbers. Both the PE and PPE 
protein families can be divided into subfamilies according to the homology and presence 
of characteristic motifs in their C-terminal domains. The largest subfamily (65 members) 
of the PE family is the polymorphic GC-rich-repetitive sequence (PGRS) subfamily. It 
contains proteins with multiple tandem repeats of a glycine-glycine-alanine (Gly-Gly-Ala) 
or a glycine-glycine-asparagine (Gly-Gly-Asn) motif in the C-terminal domain (Cole et 
al., 1998); Campus et al., 2002). 
Although the function of the 168 members of the PE and PPE protein families has not 
been established, various hypotheses have been advanced. The fact that these genes 
encode about 4% of the total protein species in the organism (if all genes are expressed) 
suggests that they most probably fulfil important functions in the organism. Genes of 
PE/PPE gene family are speculated to have varied functions from antigenic variation to 
resistance to being killed in macrophages and granulomas (Li et al., 2005); (Cole et al., 
1998); (Brennan and Delogu, 2002); (Ramakrishnan et al., 2000). The most widely 
supported theory suggests the involvement of these proteins in antigenic variation due to 
the highly polymorphic nature of their C-terminal domains (Gey van Pittius et al., 2006).  
In earlier studies using transposon mutant libraries and differential fluorescence induction 
(DFI), to screen for virulent genes associated with inhibiting PM, mycobacterial survival 
during infection and granuloma formation, a number of hits has been mapped to genes 
belonging to GC rich PE and PPE gene families (Pethe et al., 2004); (Sassetti and Rubin, 
2003); (Ramakrishnan et al., 2000). A PPE gene of M. avium (Rv1787) was also shown to 
provide resistance to killing by macrophages and the mutant was reported to be delivered 
to PL. Using our screening technique we were able to identify four distinct interruptions 
in genes homologous to Rv1918c (PPE 35). Mutants N10 and N21 had independent 
insertions in the same locus and in N16 and N29 the transposon had inserted in a distant 
region but all of their sequences shared homology with Rv1918c and within their own 
group. Two separate insertions in N5 and N75 were mapped to another PPE gene 
(Rv1135c). In mutants N13 and N81 genes homologous to PE-PGRS genes were 
inactivated. PE-PGRS (proline-glutamine – polymorphic GC rich repetitive sequence) 
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gene interrupted in N13 shared homology with MAG24-1 (Rv2328), MAG24-2 and 
MAG24-3 which are postulated to contribute to the microbe’s persistence in granulomas 
[Ramakrishnan, 2000]. Identification of PE/PPE genes in every aspect of mycobacterial 
pathogenesis demands extensive research to define the functional role of the genes 
belonging to this gene family which are abundantly distributed throughout the 
mycobacterial genomes. 
5.1.2 Membrane Transporters  
RND proteins (resistance, nodulation, and cell division proteins) are a family of multi-
drug resistance pumps that recognize and mediate the transport of a great diversity of 
cationic, anionic, or neutral compounds, including various drugs, heavy metals, aliphatic 
and aromatic solvents, bile salts, fatty acids, detergents, and dyes. RND pumps are large 
proteins ranging from 800 to 1,100 amino acids that are characterized by the presence of 
12 transmembrane domains (TMD) and two extracytoplasmic loops of approximately 300 
amino acids located between the first and second TMD and the seventh and eighth TMD 
(Paulsen et al., 1996).  RND proteins have been reported in the genomes of organisms 
from all major kingdoms of life. Mycobacterial membrane protein large (MmpL) family 
of proteins belongs to the RND (resistance, nodulation and cell division) permease 
superfamily transporters (Tseng et al., 1999). The M. tuberculosis genome contains 13 
genes coding for MmpLs (Cole et al., 1998). A mutant with a transposon insertion in 
mmpL7 has been shown to be defective in transporting PDIM (Cox et al., 1999), 
(Camacho et al., 2001) and MmpL8 transports a precursor molecule to outer cell envelope 
for the synthesis of sulfolipid (Domenech et al., 2005). Of all the mmpL mutants 
previously evaluated in M. tuberculosis mutants, in mmpL4 and mmpL7 were the only 
mutants showing impaired growth during the initial phase of infection in mice. ORF 
Rv0450c codes for MmpL4 while the adjacent Rv0451c is a small gene termed mmpS. 
Both are associated with four of the 13 mmpL genes (mmpL1, mmpL2, mmpL4 and 
mmpL5) identified so far (Domenech et al., 2005). It is noteworthy that our screen isolated 
two mutants N68 and N4R in ORFs identical to Rv0450c and Rv0451c respectively. 
Isolation of mutants having insertions in mmpL4 and its neighbour mmpS could imply that 
these two genes are together involved in transport of a molecule which could be involved 
in interfering with the early innate immune responses of the host i.e. arresting PM. This 
hypothesis is in agreement with the notion that the protein MmpS may be a functional 
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equivalent of the periplasmic membrane fusion protein (MFP), which are associated with 
RND efflux pumps of gram negative bacteria (Domenech et al., 2005). 
5.1.3 Porins 
The porins of M. tuberculosis are medically the most relevant porins. Mycobacterial cell 
envelope is highly hydrophobic and porins are thought to be the key proteins for the 
uptake of hydrophilic drugs.  This view is based on the fact that three out of the four 
current first line TB drugs, namely isoniazid, ethambutol and pyrazinamide, are small and 
hydrophilic molecules (Niederweis, 2003). An open reading frame (Rv0899), 
corresponding to the OmpA family of outer membrane proteins has been located and 
named as OmpATB (Senaratne et al., 1998). OmpATB is postulated to be the major 
active porin at growth conditions with low pH. ompATB mutant had a reduced virulence 
in macrophages and in mice. The reduced virulence of ompATB mutant has been 
attributed to the acidic milieu of the phagocytic vacuoles and is reasoned that higher 
expression of OmpATB at lower pH could help the bacteria survive in such acidic 
conditions (Raynaud et al., 2002). Selection of a mutant N74 having an insertion in a gene 
homologous to Rv0899 from our screen corroborates the above finding.  
5.1.4 β-Propeller Protein 
Our screen also identified mutant with a transposon insertion in a gene homologous to 
Rv1057. Rv1057 shares similarities with surface layer proteins of Mehanosarcina. 
Bioinformatic evaluation has found Rv1057 encoding for the only seven-bladed β-
propeller in the M. tuberculosis genome. β-propeller proteins perform extremely 
diversified functions including enzyme catalysis, signal transduction, ligand binding, 
transport, mediation of protein-protein interactions, control of cell division, and 
modulation of gene expression. Using selective capture of transcribed sequence (SCOTS) 
Rv1057 was found to be expressed during early phase of M. tuberculosis growth in 
macrophages (Haydel and Clark-Curtiss, 2006). 
5.1.5 FtsH 
We also obtained mutants with transposon insertions in genes encoding for FtsH protease 
(N27 – Rv3610c). FtsH is an ATP dependent endopeptidase believed to have a role in the 
quality control of membrane proteins. E.coli FtsH protease is shown to maintain a balance 
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between SecY and SecE production in order to form a stable translocon (Ito and Akiyama, 
2005). FtsH is also studied to be an important regulator for the production of membrane 
lipid components in E.coli (Ogura et al., 1999). In M. tuberculosis FtsH is characterised as 
an immunodominant antigen (Amara et al., 1998) and expression of the M. smegmatis 
ftsH gene in E.coli, led to a proteolytic active product that was toxic to E. coli and resulted 
in growth arrest and filamentation of the bacteria (Anilkumar et al., 2004). In 
mycobacteria FtsH is thought to have diverse functions helpful for adaptation to life inside 
the host.  Investigating the membrane proteins regulated by FtsH in mycobacteria and 
their possible role in regulating the membrane lipids of mycobacteria might result in the 
usage of FtsH as a potential antibiotic target. 
5.1.6 Genes Encoding Unknown/Hypothetical Proteins 
Another common appearance in genetic screens has been the category of genes of 
hypothetical/unknown functions. In a recent study of genes upregulated in pulmonary 
tissue samples from TB patients, the majority of upregulated genes in Mtb were those of 
unknown functions (Rachman et al., 2006). This is paralleled by our study finding that 
more than 30% of the genes identified are also of unknown function. A closer look at 
these genes revealed that a significant number (10) of these genes have orthologues in the 
M. tuberculosis genome and are annotated there as putative membrane proteins. It is of 
particular interest that N66, N6, N9 and N15 had independent insertions in the same ORF 
of an unknown gene. The H37Rv homologue of this gene is designated as Rv0365c. The 
only study addressing this gene showed an increased resistance to killing by human 
macrophages when expressed in the avirulent M. smegmatis (Miller and Shinnick, 2001). 
Our study also yielded mutants of note, bearing transposon insertions in genes sharing 
homology with Rv3881c (N36) and Rv1038c (N23). Gao and colleagues had already 
pinned on a region between Rv3866 and Rv3881c in a screen to isolate M. marinum 
transposon mutants failing to cause haemolysis, Rv3881c is a conserved hypothetical 
alanine and glycine rich protein and the authors reported that disruption of the M. 
marinum homologue of Rv3881c led to a severely attenuated phenotype in macrophages 
and in vivo (Gao et al., 2004). Rv1038c (Esxj) belongs to the ESAT-6 protein family 
mentioned above. The significance of the Rv1038c has been shown before in a study 
using 2D-Gel electrophoresis and mass spectrophotometry of secreted proteins of the 
virulent Mtb H37Rv and the less virulent H37Ra strain. One of the three spots identified 
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in this study shared homology with Rv1038c, Rv2347c, Rv2346c and Rv3620c. These 
genes carry multiple inactivating mutations in the less virulent H37Ra strain (He et al., 
2003).  
5.1.7 Genes Involved in Biosynthesis of Cell Envelope Associated Lipids 
The mycobacterial cell wall has high and complex lipid content. Consistently, a high 
proportion of mycobacterial genes are believed to be involved in lipid metabolism and 
transport (Cole et al., 1998). A number of mycobacterial lipids has been implicated in 
mycobacterial pathogenesis (Asselineau and Laneelle, 1998). Numerous roles have been 
attributed to PGLs, including the resistance of M. leprae to killing by macrophages (Neill 
and Klebanoff, 1988) and the predilection of M. leprae to peripheral nerves (Ng et al., 
2000). Importantly hypervirulent M. tuberculosis W-Beijing strain produces PGL and 
inhibits innate immune responses and shows hyperlethality in mice [Reed, 2004]. In 
particular the genes fadD26 and fadD28 have been implicated in the biosynthesis of 
phthiocerol dimycocerosate (PDIM) (Camacho et al., 2001) and have been isolated in a 
previous similar screen by Pethe et al (Pethe et al., 2004). fadD28 mutant was also found 
by Rengarajan et al., by screening Mtb for mutants unable to survive in macrophages 
(Rengarajan et al., 2005). In an alternative screen using M. bovis BCG fadD28 mutant was 
again found to have a reduced fitness in macrophages (Stewart et al., 2005). In contrast, 
our screen did not yield mutants in fadD28 itself, but in genes that in the M. tuberculosis 
genome are located in a proximal region, i.e. two of the mutants (N24, N33) in genes 
corresponding to fadD22 (Rv2948c) were interrupted and a third mutant had transposon 
insertion in the gene immediately upstream of fadD22 (Rv2949c). The gene fadD22 is 
present upstream of a polyketide synthase (pks15/1, Rv2947c) which has been found to 
contribute to the elongation of p-hydroxybenzoate to p-hydroxyphenylalkonic acid in 
mycobacterial strains producing phenolic glycolipid. H37Rv and related clinical strains of 
M. tuberculosis do not produce phenolic glycolipid due to a frame shift mutation between 
pks15 and pks1. The immediate upstream gene (Rv2949c) to fadD22 was recently 
characterised as chorismate pyruvate-lyase responsible for the conversion of chorismate to 
p-hydroxybenzoate which is likely to be the sole source of p-hydroxybenzoic acid in 
mycobacteria (Stadthagen et al., 2005). A role for p-hydroxybenzoic acid derivatives (p-
HBAD) secreted by all virulent strains of mycobacteria including H37Rv in mediating 
virulence has been suggested (Constant et al., 2002). Isolation of mutants with insertions 
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in fadD22 and Rv2949 (chorismate pyruvate-lyase) suggests that, fadD22 and Rv2949 
along with pks15/1 could be together involved in the production of phenolic glycolipids. It 
is also possible that p-HBAD synthesised by Rv2949 from chorismate could arbitrate the 
arrest of PM and thereby mediate virulence as proposed by Constant et al. (Constant et al., 
2002). Selection of multiple mutants with disruption in genes involved in PGL synthesis 
and its secreted precursor, p-HBAD, may indicate that PGL, p-HBAD or both could 
facilitate mycobacteria to reside in immature phagosomes. The screen also provided a 
mutant with a transposon insertion in a gene homologous to Rv2959c. This gene has been 
discovered to catalyze the o-methylation of the hydroxyl group located on carbon 2 of the 
rhamnosyl residue linked to the phenolic group of PGL and p-HBAD produced by 
M. tuberculosis (Perez et al., 2004). Isolation of this particular mutant having an insertion 
in a gene identical to Rv2959c from the PL fraction prompts us to hypothesise that an 
unaltered structure of PGL or p-HBAD is required by mycobacteria to accomplish a niche 
in the phagosome. Though further understanding of these mutants and elucidation of the 
mechanism by which PGL, p-HBAD or both mediate the arrest of PM is needed, from 
these observations it seems highly likely that these glycolipids play a cooperative role in 
preventing PM.  
5.2 Other Genes of Importance 
We also obtained two mutants (N76 and N77) harbouring separate insertions in a gene 
encoding a probable methyltransferase which could be involved in fatty acid biosynthesis. 
In another mutant (N92) a gene homologous to Rv3398 (idsA) was interrupted. The 
encoded gene product of Rv3398 belongs to a novel unique class of, ω,E,E-farnesyl 
diphosphate synthases involved in isoprenoid biosynthesis pathways. It is claimed to be 
unique as it is the first eubacterial ω,E,E-farnesyl diphosphate synthase that does not have 
four amino acids between the aspartate residues of the FARM and that has features of the 
archaeal CLD region (Dhiman et al., 2004). Sassetti et al., observed attenuated in vitro 
growth in a mutant having a disruption in Rv3398 (Sassetti and Rubin, 2003), but in our 
study a difference in in vitro growth could not be observed. Earlier Pethe et al., in their 
attempt to identify mutants unable to prevent PM identified three independent insertions 
in an operon of five genes having roles in isoprenol biosynthesis or modifications. One of 
the insertions was reported to be in an intergenic region upstream of idsB (Pethe et al., 
2004).  
   
107
Another mutant N47 having an insertion in a gene homologous to an Mtb gene coding for 
a probable phytoene dehydrogenase was also identified. These results indicate that the 
isoprenol metabolic pathway is important for virulent mycobacteria in a phagolysosomal 
environment. 
Mutants with transposon insertions in genes involved in amino acid metabolism and 
nucleotide metabolism were also observed. Upregulation of genes of the amino acid 
metabolism pathway has been attributed to a nutrient deprived environment and 
upregulation of nucleotide metabolism and nucleotide repair genes are considered to be 
the consequence of an atmosphere enriched in agents that damage nucleic acids (Rachman 
et al., 2006).  
Our results describing the diversity of mycobacterial genes involved in retarding of PM 
are in general in accordance with previous reports (Pethe et al., 2004); (Stewart et al., 
2005). Any discrepancies in genes identified could be due to the difference in 
mycobacterial strains, cell culture system and infection or other experimental conditions 
used in the studies.  
(1) Mycobacterial strains – for instance our screen yielded genes related to PGL synthesis 
in contrast to identification of genes related to PDIM synthesis using strains of 
M. tuberculosis [Pethe, 2004] and M. bovis BCG Pasteur (Stewart et al., 2005). (2) Cell 
culture system used – Different intensities of staining for lysosomal membrane 
glycoproteins and cathepsin-D staining in different cell systems have been observed 
(Clemens, 1996); (Xu et al., 1994). The discrepancies have been attributed to the different 
cell culture systems used (HMDM and bone marrow derived mouse macrophages). It is 
also reasoned that nitric oxide is readily induced in mouse macrophages but not in 
HMDM on stimulus with mycobacteria (Clemens, 1996). (3) Earlier studies have 
performed infections for shorter time periods; instead, our experiments were aimed at later 
stages of PM. This could lead to the identification of different subsets. Further 
M. tuberculosis phagosomes are said to exhibit heterogeneity in macrophages, even within 
the same macrophage, as observed from staining for different phagosomal markers 
(Clemens, 1996). Hence mutants were chased for longer duration in order to maintain 
maximum possible homogeneity. Moreover clumps of mycobacteria have been observed 
by us and others to proceed to the PL (Clemens and Horwitz, 1995). It has also been 
studied that phagosomes containing multiple hydrophobic beads mature in contrast to a 
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single hydrophobic bead, which possesses a close and tight apposition to the phagosomal 
membrane (de Chastellier and Thilo, 1997). We took utmost care to disperse the clumps 
into single bacilli to perform the screen. Therefore we were able to isolate PL mutants in 
which gene coding for secreted and many membrane proteins were disrupted. In the 
screens done by other groups, underrepresentation of such genes has been speculated to be 
due to cross complementation (Stewart et al., 2005).  
In spite of the differences observed many of the genes identified through our screen have 
been identified by others individually as virulent genes in other mycobacterial species 
including Mtb. Identified genes were also found to have an effect on the survival fitness of 
mycobacteria in macrophages. This proves the validity of our screen and the usage of M. 
marinum as a model organism to study mycobacterial virulence principles. Moreover, our 
genetic screen corroborates the hypothesis that multiple effectors cooperate in establishing 
a niche in the phagosomes of the host’s phagocytes (Russell, 2001).  
5.3 Efficient Transfection System to Study Phagosome Maturation 
Different Rab-GTPases mark different stages of PM. Therefore Rab-GTPases are useful 
markers to study PM. Retroviral Rab-GFP fusion constructs have been used in J774 
macrophage cell line and bone marrow derived mouse macrophages to study MP (Kelley 
and Schorey, 2003, 2004). Primary HMDM are terminally differentiated cells and they are 
unable to divide, thus it is impossible to deliver a gene using retroviral vectors. Instead, 
adenoviral viral vectors are attractive vehicles among other viral vectors for gene delivery, 
as they are able to transfect a large variety of cells including those in quiescent state. They 
have also been used in gene therapy experiments to transfect macrophages (Haddada et 
al., 1993); (Schneider et al., 1997). Therefore, Rab-GFP fusion adenoviral constructs were 
designed to transfect macrophages. Flowcytometric analysis on the transfected cells 
revealed excellent transfection potency of the Rab-GFP adenoviral constructs. Moreover, 
these constructs were also capable of transfecting primary mouse dendritic cells and 
activated peritoneal macrophages effectively. 
5.4 Mutant P1 is Defective in Inhibiting Phagosome Maturation 
The validity of a screen can be assessed only by demonstrating that at least some of the 
mutants have the predicted phenotype (Pethe et al., 2004). We looked for the co-
localisation of phagosomal markers Rab5 and Rab7 and LAMP1 with phagosomes 
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containing mutant as the arrest of PM has been shown to occur between stages controlled 
by Rab5 and Rab7 (Via et al., 1997). Immunofluorescence microscopy identified a mutant 
P1 of which approximately 70% of the phagosomes acquired markers of late endosomes 
and were not found to retain the early endosomal marker Rab5.  Co-elution of 
radiolabelled bacteria with PL marker showed enrichment of the P1 in PL compared to 
that of the WT and the P1[pGPC352], signifying PM.  As expected for mutants defective 
in preventing PM, P1 has a diminished survival in macrophages and is severely attenuated 
in vivo in mice. Histopathological analysis of the P1 infected organs showed reduced 
pathological changes with fewer granulomas in liver and spleen, a macrophage mediated 
reaction.  Together these results strongly suggest that the gene pmiA that is inactivated in 
P1 takes part in modulating PM. 
5.5 Gene pmiA is Involved in Phenolic Glycolipid Biosynthesis 
The most striking observation was that P1 when recovered from the organs of mice 
produced flat, smooth and transparent colonies. Lipid biosynthesis and fatty acid 
modifying genes have been found to be upregulated in an intracellular milieu up to twice 
the activity of the normal level. From these observations it has been inferred that 
M. tuberculosis undergoes immense changes in cell envelope composition upon infection 
and that these microbes are capable of mobilising mechanisms to evade host immune 
responses by modifying lipid and cell wall components (Rachman et al., 2006). Our 
observations substantiate this hypothesis. Altered colony morphology of the mutant P1 
was due to a defect in cording as observed microscopically. Correlation between virulence 
and cording has long been appreciated. Virulent mycobacteria form braided serpentine 
cords as noted by Koch. The cord forming capacity is attributed to multiple cell envelope 
lipids. In M. tuberculosis cording requires cycloproponation of mycolic acids while in 
M. marinum disruption of kasB leads to non-cording colonies (Glickman et al., 2000); 
(Gao et al., 2003b). Although mycolic acid synthesis is unaffected in our mutant P1, a 
systematic lipid profiling identifies a lipid of the outer cellular envelope in the WT that is 
missing in the mutant P1. When complemented the mutant regains the lipid moiety. These 
results suggest a function for the gene pmiA in lipid metabolism or transport which would 
also correspond closely to the analogy based assumption that adjacent putative hydrolase 
(MM3387) and carboxylase (MM3388) genes that are presumably involved in fatty acid 
metabolism (Cole et al., 1998). The mycobacterial cell envelope is composed of an 
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unparalleled variety of complex lipids. Very little knowledge is available on the genetics 
of these lipids and their physiological role. Our results reveal the involvement of a so far 
uncharacterised gene adjacent to a putative hydrolase and carboxylase genes in lipid 
metabolism. Moreover, biochemical characterization of lipids of bacteria grown in 7H9 
broth containing [14C] p-hydroxy benzoic acid and structural characterization of the lipid 
missing in mutant P1 by ES/MS and NMR reveal that the lipid is a phenolic glycolipid. M. 
marinum along with other virulent strains are known to produce phenolic glycolipids. 
Although not much is known about the physiological role of PGL produced by M. 
marinum in particular, numerous roles have been attributed to PGLs in general, including 
the resistance of M. leprae to killing by macrophages (Neill and Klebanoff, 1988) and the 
predilection of M. leprae to peripheral nerves (Ng et al., 2000). Importantly hypervirulent 
M. tuberculosis W-Beijing strain produces PGL and inhibits innate immune responses and 
shows hyperlethality in mice (Reed et al., 2004). Recently it was also shown that many of 
the clinical isolates possess an intact pks15/1 region, which has been clearly shown to be 
important for the biosynthesis of PGL. Considering the fact that PGL is not secreted by all 
the strains of M. tuberculosis it is likely that an alternative molecule could be involved in 
hampering PM. In this regard, our screen identified genes related to PGL, whereas other 
screens prompted genes related to PDIM synthesis. These at first sight conflicting results 
can be brought together if it is considered that M. marinum utilizes PGL instead of PDIM 
for inhibition of PM. In a general sense, it has been suggested that lack of one virulence 
factor might be compensated by the over production of other factors (Constant et al., 
2002). Following that line of argument PGL and PDIM could be used interchangeably by 
virulent mycobacteria. The mutants defective in PGL biosynthesis were also found to be 
enriched in the PL.  It is compelling to speculate from these results along with the 
identification of many more mutants defective in PGL synthesis through our screen that 
PGL could be an inhibitor of phagosome maturation. 
5.6 PGL Inhibits Phagosome Maturation 
Previous reports have shown that mycobacterial lipids including PGL can modify 
membranes (Sut et al., 1990) and also prevent actin nucleation, a prerequisite for PM 
(Anes et al., 2003). In addition, the glycolipids PIMs are shown to mediate selective 
fusion with early endosomes and yet another glycolipid LAM prevents mycobacterial 
phagosomes from fusing with late endosomes. All these reports implicate mycobacterial 
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lipids as key factors in the prevention of PM. As discussed earlier our screen identified 
mutants having transposon insertions in genes presumably involved in the synthesis of 
PGL or its precursors. Our work identifies a novel gene pmiA that has a role to play in the 
synthesis of PGL. These evidences prompted us to track the phagosomes containing PGL-
coated beads. As expected, PGL-coated beads were restricted to early endosome like 
phagosomes. Phagosomes containing PGL-coated beads were marked by the presence of 
Rab5-GTPase, a marker for early endosomes and devoid of mature β-galactosidase a 
hydrolytic enzyme characteristic for lysosomes. Immunofluorescence microscopy for 
LAMP-2 confirmed that the PGL-coated beads retarded phagosome maturation. These 
data lead highly convincingly to the conclusion that M. marinum PGL is an important 
molecule employed by the pathogen to create a niche for itself in macrophages, an 
unknown function till date.  
The cellular events in the host cell permitting this niche remain ill-defined. PGL of 
M. leprae has been found to scavenge oxygen radicals generated upon IFN-γ stimulation. 
This is considered to be important for the intracellular persistence of M. leprae. Infection 
of bone marrow derived macrophages with a Mtb Beijing strain that produces PGL and a 
mutant defective in the synthesis of PGL revealed an inverse correlation between PGL 
production and the level of secretion of the pro-inflammatory mediators TNF-α, IL-6, IL-
12 and MCP-1 (monocyte chemotactic protein-1). Also, PGL from Beijing strain was able 
to inhibit innate immune responses by down regulating pro-inflammatory cytokines 
induced by apolar lipids of H37Rv (Reed et al., 2004). Furthermore, it is known that 
activation of macrophages with IFN-γ leads to maturation of MP (Via et al., 1998). 
Moreover, M. avium containing phagosomes acidify upon treatment with IFN-γ, resulting 
in PM (Schaible et al., 1998). Taking these observations together it can be speculated that 
by down regulating pro-inflammatory cytokines PGL probably inhibits macrophage 
activation, thereby arresting PM.  
Recently cytokines have been implicated in the modulation of phagosome maturation by 
modulating Rab-GTPase expression. IL-12 increases expression of Rab7 and IL-6 induces 
Rab-5 (Bhattacharya et al., 2006).  In antigen presenting cells cytokines are mainly 
regulated via Toll like receptor (TLR) signalling. It is also known that TLRs are recruited 
to phagosomes upon phagocytosis and they have a critical role in phagosomal processing 
through their downstream signalling (Underhill et al., 1999). It has also been documented 
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that knock down of TLRs and its adaptor molecule Myd88 result in impaired PM (Blander 
and Medzhitov, 2004). Moreover, p38 MAP kinases stimulated upon TLR activation 
dissociate Rab5 from the phagosome through the activation of guanosine dissociation 
inhibitor (GDI) (Blander, 2007). Taking these findings and our observation that Rab5 does 
not dissociate from phagosomes containing PGL coated beads into consideration, it is 
perceivable that PGL interferes with TLR signalling cascade thereby arresting PM (Fig-
31). M. marinum is one of the mycobacterial species producing PGL and was structurally 
characterised by Dobson and colleagues (Dobson et al., 1990) but the functional 
characteristics of M. marinum PGL remained undefined to date. This work for the first 
time demonstrates inhibition of PM by PGL, an important trait of mycobacterial 
pathogenesis. 
 
Fig 31: Possible intracellular targets of PGL. 
Mycobacteria undergo receptor mediated phagocytosis, but the phagosomes containing 
mycobacteria or phenolic glycolipid (PGL) coated beads do not fuse with late endosomes (LE) and 
lysosomes (Lys). However, they interact with early endosomes (EE) and acquire markers of EE, 
namely Rab5. Toll like receptors (TLR) are the likely candidate receptors to recognise PGL. TLRs 
are recruited to the phagosomes and are activated on recognition of its ligand. Upon activation of 
the TLR adaptor protein namely myeloid differentiation factor 88 (MyD88) transduce a cascade of 
signalling events leading to the activation of p38 mitogen activated kinase (p38 MAPK), 
extracellular signal-regulated kinase 1 and 2 (ERK 1 / 2), c-Jun NH2-terminal kinase (JNK) and 
translocation of NF-κB (Nuclear factor-κB). The signalling cascade leads to the induction of pro-
inflammatory cytokines. Pro-inflammatory cytokines modulate the expression of fusion mediating 
Rab-GTPases (Rab5 and Rab7). Moreover, p38 MAPK phosphorylates guanine dissociation 
factor which in turn dissociates Rab5 from the phagosome permitting maturation. It is possible that 
PGL interferes with TLR signalling at different levels in the TLR signalling cascade (shown using 
red lines), thus impairing phagosome maturation. 
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5.7 PmiA, its Interacting Partners and their Function in Lipid Metabolism 
A novel gene has been identified which participates in the biosynthesis of PGL. The gene 
and its protein product do not share any significant homology with the known genes or 
proteins identified so far. Therefore, an attempt was made to identify its interacting 
partners using a His-tag pull down assay. His-tagged PmiA pulled down two proteins 
namely a methyl transferase and isocitrate lyase (ICL). A similar Mtb methyl transferase 
has been earlier proved to be responsible for the terminal cyclopropanation of mycolic 
acids. It is plausible that these methyl transferases are involved in the methylation of PGL.  
There is accumulating evidence suggesting that mycobacteria subsist primarily on fatty 
acids rather than on carbohydrates. When bacteria are grown on fatty acids as the principal 
carbon source, replenishment of citric acid cycle intermediates (anaplerosis) occurs via the 
glyoxylate cycle, which converts acetyl-coA derived from β-fatty acid oxidation to 
oxaloacetate. ICL, the first enzyme in the glyoxylate cycle, is upregulated in dormant 
cultures of Mtb under low oxygen tension. In addition, icl expression is upregulated 
during infection of macrophages [Graham and Clark-Curtiss, 1999; Sturgill-Koszycki, 
1997]. Mtb genome contains two genes coding for ICL icl1 and icl2. An icl1 knock out 
mutant was still able to cause acute infection but failed to establish a chronic infection. 
Mycobacteria lacking both icl1 and icl2 were unable to grow on fatty acids or in 
macrophages (Munoz-Elias and McKinney, 2005). Moreover, ICL1 is proposed to have 
dual function in glyoxylate cycle and in methyl citrate cycle through which propionyl-coA 
derived from β-fatty oxidation of odd chain carbon atoms is detoxified. A link between 
ICL and pmiA remains to be established. It has been reported that anaerobic bacteria such 
as Pseudomonas sp degrade phenol to p-hydroxybenzoate via carboxylation (Tschech and 
Fuchs, 1987). p-hydroxybenzoate is also a precursor for PGL synthesis (Stadthagen et al., 
2005). It is possible that ICL along with pmiA and other enzymes is also involved in the 
degradation of hydroxybenzoyl-coA derived upon phenol catabolism. These results 
demonstrate that PmiA along with other proteins could function as a complex in the 
biosynthesis of PGL. 
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 6  Conclusion 
The persistence of Mycobacterium tuberculosis in humans depends predominantly on its 
ability to survive within the host macrophages. This ability also assists the bacilli to survive in 
the host for extended time periods in a state of clinical latency. Virulent mycobacteria using 
their currently ill-defined pathogenic principles achieve this phenomenon by inhibiting 
phagosome maturation in macrophages.  
This thesis demonstrates an elegant screen using Mycobacterium marinum to identify 
mycobacterial genes orchestrating the inhibition of phagosome maturation. A number of 
genes having possible roles in arresting fusion of phagosomes with lysosomes have been 
identified using this screening technique. Further, a novel gene pmiA involved in the 
biosynthesis of an outer envelope glycolipid has been discovered to play a major role in 
stalling phagosome maturation and this glycolipid is characterised to be a phenolic glycolipid 
(PGL). Moreover, for the first time PGL is shown to be a key factor in the modulation of 
phagosome maturation.  
Mycobacterial lipids have long been thought to play key roles in the pathogenesis of 
tuberculosis. This study reemphasises mycobacterial lipids as dominant pathogenic principles 
in mycobacterial pathogenesis. Mycobacterial strains producing PGL downregulate pro-
inflammatory cytokines therefore are considered to be more virulent than the strains that do 
not produce PGL. It is conceivable that PGL arrests phagosome maturation either by diverting 
intracellular signalling or by interfering with intracellular signalling leading to cytokine 
induction.   
This finding that PGL inhibits phagosome maturation stimulates follow-up studies to identify 
receptors and signal transduction pathways targeted by PGL for immunomodulation and 
inhibition of phagosomal processing. This study also portrays genes participating in the 
synthesis of PGL as ideal targets for developing anti-tuberculosis drugs and also highlights 
PGL as a possible antigen for vaccine development. 
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 8  Abreviations 
αSNAP Alpha-soluble NSF attachment protein 
AG Arabinogalactan 
AIDS Acquired immune deficiency syndrome 
Amp Ampicillin 
AraLAM Arabinose Lipoarabinomanan 
ATCC American type culture collection 
ATP Adenosine tri phosphate 
ATPase Adenosine tri phosphatase 
BCG Bacillus Calmette-Guèrin 
BSA Bovine serum albumin 
Ca2+ Calcium 
CaMKII Calmodulin complex II 
cAMP Cyclic adenosine mono phosphate 
CFP-10 10 kilo dalton Culture filtrate protein  
CFU Colony forming units 
CPM Counts per minute 
CuSO4 Copper Sulphate 
DAG Diacylglycerol 
DC Dendritic cells 
DeADMAn Designer arrays for defined mutant analysis 
DFI Differential fluorescence induction 
DHFRS Dihydrofolate reductase 
DIG Digoxigenin 
DMEM Dulbecos minimum essential medium 
DNA Deoxy ribo nucleic acid 
DTT Dithiothreitol 
E.coli Escherichia coli 
ECL Enhanced chemiluminescence (?) 
EDTA Ethylene diamine tetraacetic acid 
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EE Early endosomes 
EEA1 Early endosomal antigen 1 
EGTA Ethylene glycol tetraacetic acid 
EMBL European Molecular Biology Laboratory 
ER Endoplasmic Reticulum 
ES/MS Electrospray mass spectrometry 
ESAT-6 Early secreted antigen 
ESI-TOF Electro spray inonisation – time of flight 
FACS Fluorescence activated cell sorter 
FBS Foetal bovine serum 
FITC Fluorescein isothiocyanate 
GAPDH Glycerinaldehyde-3-phosphate- dehydrogenase 
GC Guanosine Cytosine 
GDI Guanine nucleotide dissociation inhibitor 
GFP Green Fluorescent protein 
Gly-Gly-Ala Glycine-Glycine-alanine 
Gly-Gly-Asn Glycine-glycine-asparagine  
GPLs Glycopeptidolipidis 
GTP Guanosine tri phosphate 
GTPase Guanosine tri phosphatase 
HCl Hydrochloric acid 
HEK Human embryonic kidney
His Histidine 
HMDM Human Monocyte Derived Macrophages 
HPLC High performance liquid chromatographic 
HPTLC High performance thin layer chromatography 
Hrs Hepatocyte growth factor-regulated tyrosine kinase substrate
H2SO4 Slulphuric acid 
Hyg Hygromycin 
ICL Isocitrate lyase 
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IFN-γ Interferon gamma 
IgG Immunoglobulin G 
IL Interleukin 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
Kana Kanamycin 
Kb Kilo bases 
KCI Potassium chloride 
kDa Kilo dalton 
KOD Thermococcus kodakaraensis polymerase
KOH Potassium hydroxide 
Kv Kilo volt 
LAM Lipoarbinomanan 
LAMP Lysosome asscociated membrane protein 
LB Luria-Bertani 
LBPA Lysobisphosphatidi c acid 
LE Late endosome 
LOS Lipooligosaccharides 
M. avium Mycobacterium avium 
MACS Magnetic cell sorting 
MALDI Matrix assisted laser desorption/ionization 
ManLAM Mannose Lipoarabinomannan 
MCP-1 Macrophage chemotactic protein-1 
MFP Membrane fusion protein 
Mg Magnesium 
MgCI Magnesium Chloride 
MHC Major Histocompatibility complex 
MmpLs Mycobaterial membrane protein large 
mmpS Mycobacterial membrane protein small 
MOI Multiplicity of Infection 
MP Mycobacterial phagosome 
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mRNA Messenger RNA 
MS Mass spectrometry 
Mtb Mycobacterium tuberculosis 
NaCl Sodium Chloride 
NADPH Nicotinamide adenine dinucleotide phosphate 
NaHCO3 Sodium bi carbonate 
NaHPO4 Sodium hydrogen phosphate 
NaOH Sodium hydroxide 
Ni-NTA Nickel-nitrilotriacetic acid 
NK Natural killer 
NMR Nuclear Magnetic Resonance 
NSF N-ethylmaleimide-sensitive fusion protein 
OADC Oleic acid albumin dextrose complex 
OD Optical density 
OmpA Outer membrane protein A 
ORF Open reading frame 
PI3K Phosphoinositol-3-kinase 
PI3P Phosphoinositol-3-phosphate 
PBS Phosphate buffer saline 
PCR Polymerase chain reaction 
PDIM Phthiocerol di mycocerosate 
PE Proline-Glutamine 
PE-PGRS Proline-glutamine – polymorphic GC-rich repetitive sequence 
PGL Phenolic Glycolipid 
PGRS Polymorphic GC-rich-repetitive sequence (?) 
p-HBAD P-hydroxybenzoic acid derivatives 
PI3P Phosphatidylinositol 3-phosphate 
PIM Phosphoinositol mannoside 
PIPES Piperazine-N,N´-bis ethansulfonic acid (?) 
PknA Protein kinaseA 
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pks Polyketide synthase 
PL Phagolsosome 
PM Phagosome maturation 
pmiA Phagosome maturation inhibition A 
PMSF Phenylmethylsulphonyl fluoride 
PPE Proline-Proline-Glutamine  
ppm Parts per million 
PtdIns(4,5)P Phosphoinositol-4,5-bisphosphate 
PVDF Polyvinylidene difluoride 
RF Retention factor 
RGD Arginine-glycine-aspargine  
RILP Rab7-interacting lysosomal protein 
RNA Ribo nucleic acid 
RND Resistance, nodulation, and cell division proteins 
rpm Rotations per minute 
RPMI Roswell Park Memorial Institute medium 
RT Room temperature 
SapM Secreted mycobacterial lipid phosphatase 
SCOTS Selective capture of trancribed sequence 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate Poly acrylamide gel electrophoresis 
SE Sorting endosomes 
SFM Serum free medium 
SMART Simple Modular Architecture Research Tool 
STM Signature tagged mutagenesis 
TB Tuberculosis 
TC Tissue culture 
TDM Trehalose dimycolate 
TE Tris EDTA 
Tf Transferrin 
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Tfr Transferrin receptor 
TGN Trans Golgi network 
TLC Thinlayer chromatography 
TLR Toll like receptor 
TMD Transmembrane domains 
Tn Transposon 
TNF-α Tumor necrosis factor alpha 
TraSH Transposon site hybridization 
TRITC Tetramethylrhodamine-5-isothiocyanate 
UV Ultra violet 
WHO World health organisation 
WT Wild-type 
WTHK Wild-type heat killed 
YFP Yellow fluorescent protein 
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